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EPMAwas created in 2009 as the Forum for Predictive, Preventive and
Personalised Medicine (PPPM). During the 8 years since then, EPMA
meetings – in the form of world congresses and international summits [1-
3] – have traditionally included multi-professional presentations, discus-
sions, considerations, publications, and consolidation in the field of
PPPM. The EPMA Journal releases over 90% of publications dedicated
to PPPM worldwide, acting as the leading journal in the field. EPMA
currently comprises a network of over 50 countries globally, actively
contributing to the innovative concepts of PPPM. For more information,
please see www.epmanet.eu
The EPMAWorld Congress 2017 in Malta is specifically focused on the
following topics: PPPM in Cancer, PPPM in Neurodegenerative
Neurological Neuropsychiatric Disorders (NNND), PPPM in
Cardiovascular Disease, PPPM in Diabetes Mellitus and related patholo-
gies, PPPM in Dentistry, Innovative Technologies in PPPM, and
Innovative PPPM Strategies in Healthcare.
Global challenges and PPPM-solutions: Long-term strategies of the EPMA
(keynote speech by the EPMA Secretary-General, Prof. Dr. Olga
Golubnitschaja, September 14th) will be presented based on the BEPMA
position paper 2016^ as the fundamental document of the association [4].
Several approaches have been suggested in modern medicine for
optimising medical services, including person-centred, personalised,
individualised, and precision medicine. The great plurality of approaches
indicates a broad understanding of clear deficits which do exist in cur-
rently applied medical services and the attempts of diverse professional
groups to remedy them. On the other hand, there is a growing understand-
ing that persisting deficits are fundamental in nature and, therefore, can-
not be solved by superficial modifications of health care systems facili-
tating individual technologies such as Bcancer genomics^ by Bprecision
medicine.^Global deficits are well-defined and have been described else-
where as unpredictable, unpreventable, and impersonal medicine. It is
evident that a paradigm shift is needed to move from Breactive^ to
Bpredictive, preventive and personalised medicine^ as a new philosophy
for medical services covering both Bhealth care^ and Bdisease care^, promot-
ing an integrated approach combining advantages of individual biomedical
fields and technologies, and consolidating a multi-professional collaboration.
An individual with an actual or potential disease wants a medicine in which
he/she is at the centre, a medicine which is tailored to his/her polymorphism,
amedicinewhich is able to provide him/her with the right therapy, in the right
dose, at the right moment, for the right period of time. But he/she alsowants a
medicine which is able to predict and prevent possible diseases. He/she is not
interested in the way in which this kind of medicine is described. However,
he/she is interested in understanding why it is described in that way, in order
to appreciate its potential to restore health. And this is the real advantage of
speaking in terms of predictive, preventive, and personalised medicine: the
actual or potential patient understandswhat is going on!Nevertheless, there is
something more. PPPM lends itself to the role of an overarching umbrella
under which the main ethical issues of contemporary biomedicine can be
positively tackled.
Flammer syndrome (FS) in the context of PPPM (keynote speech by Prof.
Dr. Josef Flammer and Dr. Katarzyna Konieczka, Ophthalmologic Clinic,
University of Basel, September 15th) will present a special phenotype/
health condition which is clearly relevant for disease development and
individual outcomes in several pathologies including glaucoma, multiple
sclerosis, breast cancer, and metastatic disease, amongst others [5-9]. FS
is frequently observed in young populations (the symptoms appear early
in puberty), making innovative PPPM approaches particularly meaning-
ful in the area of population screening, predictive diagnostics, targeted
prevention, and individualised prognosis.
Innovative healthcare strategies
PPPM represents only innovative biomedical sciences but also advanced
healthcare services focusing on the patient’s needs and the most optimal
solutions for society as the whole. The practical aspects of the paradigm
change from BunPPPM^ to PPPM will be discussed at dedicated sessions
including global healthcare benefits (keynote speech by Prof. Dr. Russel
Andrews, NASA, USA, September 16th), socioeconomic aspects of the
PPPM implementation, and creation of new institutions to facilitate the de-
velopment of PPPM services in healthcare.
Breast Cancer Epidemic in the early Twenty-First century [10] is the
Bleitmotiv^ of the specialised congress session BPPPM in Cancer .^ PPPM
approaches will be discussed to apply multi-level diagnostics in order to
improve the patient stratification, prediction of disease development and
progression, targeted preventive measures, and personalised treatment
algorithms [11].
PPPM in Neurological, Neurodegenerative and Neuropsychiatric
Disorders (NNND) is a specialised session which will present the top
expertise in the relevant areas including computer-assisted disease-
modelling, personalised approaches to diagnosis and treatment in psychi-
atry, neuroinflammation, neurodegeneration, suboptimal health condi-
tions, and comorbidities, amongst others.
PPPM in Diabetes Mellitus is a specialised session dedicated to the inno-
vative approaches for predicting, preventing, and effectively treating the
metabolic syndrome, its pre-stages and comorbidities, and special health
conditions such as pregnancy.
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PPPM in Cardiovascular Disease (CVD) is a specialised session featuring
a collection of innovative data regarding CVD prevention in stratified
cohorts, as well as molecular pathways targeted for CVD prediction and
prognosis.
PPPM in Dentistry is a specialised session with multi-professional
expertise which will present a whole spectrum of the field related
innovation including the role of stem cells in tooth regeneration
(keynote speech by Prof. Dr. Mahmood Mozaffari, University of
Augusta, USA, September 16th), dental health in childhood, caries
prevention in stratified patient cohorts, personalised orthopaedic
treatments, and prevention of severe complications in CVD pa-
tients with dental pathologies, amongst others.
Innovative Technologies in PPPM is a specialised session with multi-
professional expertise which will introduce unique technologies such as
liquid biopsy (keynote speech by Prof. Dr. Evi S. Lianidou, University of
Athens, Greece, September 15th), health condition-specific biomarker
panels discovered in human tear fluid and saliva, and disease-specific
multi-omics approaches, amongst others.
Workshop of young professionals in PPPM (EPMA-YPS, September
14th) is the traditional session presenting new ideas developed by young
researchers, including BMini-encyclopaedia of Wound Healing: Lessons
for PPPM^, BLongevity – good luck or reasonable lifelong healthcare
strategy?^ The best presentations chosen by the international jury-board
of prominent scientists will be awarded by the EPMA. The award cere-
mony will take place on September 16th.
The University of Malta, as the host of the EPMAWorld Congress 2017,
has created an excellent platform for an effective congress and a pleasant
atmosphere for the thematic sessions scheduled in the congress pro-
gramme, as well as spontaneous professional meetings to exchange pro-
fessional information and to plan new, successful projects in PPPM.
Welcome to the EPMAWorld Congress 2017 in Malta – enjoy the meeting!
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Abstract
The breast cancer (BC) epidemic in the twenty-first century is evi-
denced by the approximately two million new cases and half-million
related deaths annually worldwide [1]. The overall situation is particu-
larly dramatic in specific subgroups such as those with triple-negative
BC: more than 50% of these patients die of metastatic BC within the
first 6 months of diagnosis. Consequently, breast cancer management in
general should be thoroughly reconsidered, promoting a new paradigm
based on predictive diagnostics, new screening programs, targeted pre-
vention and individually tailored treatments. Due to the extremely high
level of complexity of the field, the new paradigm represents a spec-
trum of complementary components that constitute the innovative
PPPM concept. At the EPMA World Congress 2015, the dedicated
working group elaborated the working hypothesis and concepts for a
multi-centre pilot project; this action has consequently been taken [2],
and the new knowledge collected will be summarised. The overall
results substantially extend the Bseed and soil^ theory of metastasis
with the finding that among individuals at risk, a strong predisposition
toward the formation of the systemic hypoxic pre-metastatic niches can
be established long before the breast malignancy is clinically manifest-
ed [3]. The BFlammer syndrome^ phenotype may strongly contribute to
BC onset [4] and aggressive metastatic disease with particularly poor
outcomes [4]. Both pre- and postmenopausal women may be affected
[3-5]. Individualised patient profiles and the involvement of primary
caregivers (family doctors) are essential for implementation of PPPM
in BC management [5].
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Abstract
Molecular medicine has evolved rapidly over the past decade, focusing on
genetics and cellular mechanisms of disease, providing knowledge on (1)
causative genes in monogenic diseases and syndromes, as well as suscepti-
bility genes that work in concert with other genetic and environmental factors
to elicit the disease; and (2) deregulated mechanisms within specific subtypes
of disease, to classify patients molecularly and to identify potential or already
known therapeutic targets. In oncology, research and its evidence-based sci-
entific outcomes have evolved from the lab bench to bedside, implementing
the use of biomarkers as classifiers of therapeutic groups; characterization of
syndromes with high risk for specific disease, hence providing the opportu-
nity for risk reduction strategies; predictive biomarkers to guide treatment
type, dose and toxicity; and prognostic biomarkers to define specific clinical
outcomes. Preventive genetics plays a role in defining specific genetic disor-
ders through population screening for carriers of rare, fully penetrant alleles
that cause monogenic diseases, and genotyping of susceptibility genes within
families at high risk of developing a specific disease, providing the basis of
public health genetics. Predictive genetics deals with the efficacy and toxicity
of drugs in individuals. Breast cancer will be discussed as a model for the use
of molecular markers; the use of technology to bridge the gap between lab-
oratory and clinical setting; and the need for novel targets to overcome
targeted therapy resistance. The uptake of molecular medicine in the
healthcare system requires continuous education of healthcare professionals
and proper dissemination of information within the healthcare system.
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Abstract
Breast cancer (BC), the leading cancer in women, is increasing in prev-
alence worldwide, concurrent with western metabolic epidemics includ-
ing obesity, metabolic syndrome, and diabetes, and shares major risk
factors with these diseases. Here, potential dietary contributions to BC
EPMA Journal
prevention are reviewed, with a focus on their pathometabolic
trajectories.
The development of BC potentially involves diet-related pro-oxi-
dative, inflammatory, and pro-carcinogenic processes, i.e. through
lipid/fatty acid peroxidation, estrogen metabolism, related DNA
adduct depurination, and mutation formation [1]; free fatty acids
(FFA), e.g. the n-6 polyunsaturated fatty acid (PUFA) linoleic
acid, have been associated with BC migration and invasion [2].
The pathometabolic trajectory is affected by high estrogen, insulin, and
growth factor cascades and the resultant accelerated proliferation/
progression [3]. Anthropometric measures – high birth weight, adult tall-
ness, fatness/body mass index (BMI), and weight-gain – are often reflec-
tive of these factors [3, 4].
A gender-based approach targets women’s specific nutritional risk
in western obesogenic environments, i.e. with increasing adiposity,
estrogen metabolism, and n-6 PUFA conversion to pro-inflamma-
tory/carcinogenic eicosanoids under high n-6:n-3 PUFA ratio con-
ditions [5]; and as related to the timing of life events, such as
lower age at menarche, late full-term pregnancy, and early meno-
pause [6].
Recent large-scale studies have confirmed the effectiveness of evidence-
based recommendations against BC risk, emphasizing low dietary energy
density (ED), nutritious plant-based diets, physical activity, and body/
abdominal adiposity management [7, 8].
A better understanding of dietary interrelationships with BC and
recommended dietary patterns – e.g. Mediterranean, DASH, plant-
based, low-ED, and glycemic load (GL), with high nutrient/
phytonutrient density – will be discussed, with emphasis on the
need for personalized adaptation to support early/timely prevention,
optimally merging with other dietary/health goals, for lifelong BC
prevention.
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Abstract
Breast cancer is by far the most common cancer in women world-
wide. The World Health Organization (WHO) claims that there
are about 1.38 million new cases and 458,000 deaths from breast
cancer each year [1]. The Malta Cancer registry showed that 13%
of cancer deaths in Malta are due to breast cancer, the second
highest rate in the EU [2].
Exploring the molecular difference among breast cancer subtypes is
of crucial importance in understanding its heterogeneity and seeking
its effective clinical treatment. Predicting drug response in cancer
patients remains a major challenge in the clinic; one of the reasons
is heterogeneity [3]. Ex vivo culturing enables a personalized cul-
ture method, which allows for investigation of anti-tumoral pharma-
cological properties that preserves the original cancer microenviron-
ment [4]. It is believed that molecular predictive markers may form
the basis for tailoring an individual’s adjuvant therapy based on the
genetic fingerprint of their cancer.
This study aims to assess heterogeneity in breast cancer tissue
resected in Malta using both routine immunohistochemistry and
that specific to the PI3K/pAkt pathway. Using LIS, PATHSA and
iSOFT software, a curated dataset of patients who had document-
ed tumoral heterogeneity between 2008 and 2015 was created.
Demographics that were noted included gender, age, histology
types, Bloom-Richardson grade, type of surgery the patient
u n d e rwe n t , p r e s e n c e o f a x i l l a r y m i c r ome t a s t a s i s o r
macrometastasis, and vascular invasion. The tissue blocks with
confirmed heterogeneity were traced using LIS software and re-
trieved from the storage unit. Sections from these tissue blocks
were used to run tests to assess tissue architecture with H&E and
immunohistochemistry. Different techniques for ex vivo culturing
of breast tissue are explored. Results will be analysed using
SPSS.
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Abstract
Research background
The breast cancer (BC) epidemic is a hallmark of the early twenty-first cen-
tury [1]. BC is amultifactorial disease: BC experts utilise the plural form, now
referring to Bbreast cancers^ [2]. Contextually, the BC patient cohort demon-
strates the whole spectrum of subgroups, including both antipodes: on one
side this is the Bpostmenopausal breast cancer as the European challenge^ [3],
and on the other the particularly aggressive premenopausal Bmetastatic breast
cancer^ [4]. The latter subgroup is particularly unpredictable, comprising
sporadic BC cases with highly promoted metastatic spread to the vital organs
[5]. Although postmenopausal BC cases still represent the majority of the
overall patient cohort, recent statistics demonstrate that young populations are
increasingly affected by BC [1]. Therefore, the old rule "the older the age, the
higher the BC risk" is becoming relativized. Contextually, BC prediction and
consequent prevention is a highly complex task requiring effective computa-
tion of individual patient profiles and precise modelling of the disease [1].
Results and conclusions
Our pilot project dedicated to the predictive modelling of BC has utilised data
collected using a multi-level diagnostic approach in BC patients versus breast
benignancy. The study revealed two clearly separate clusters with high versus
lowBC similarity in premenopausal BC-free individuals. The developedmod-
el is capable of distinguishing Bhigh^ and Blow^ BC riskwith high confidence
(>90%). This diagnostic approach is based on a disease-specific molecular
signature including signalling and detoxification pathways, longevity-related
proteins, regulation of cytoskeleton, and tissue remodelling. Large-scale vali-
dation of the clinical utility of the model is under consideration.
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Abstract
The breast cancer (BC) epidemic is currently recognised as a feature of
the early twenty-first century, with almost two million new cases and a
half-million BC-related deaths recorded annually [1]. Over 90% of all BC
cases are sporadic in nature, which means currently unpredictable. The
main cause of BC-related deaths is aggressivemetastatic disease to distant
organs – bones, lung, liver and brain, amongst others.
The premenopausal triple-negative breast cancer (pTNBC) subtype is
characterised by particularly low predictability and poor prognosis: early
diagnostic methods are underdeveloped and therapy approaches are rath-
er un-targeted. Consequently, more than 50% of these patients die within
the first 6 months of the diagnosis of metastatic disease [2], and up to 30%
experience brain metastasis, with particularly poor outcomes [3].
Individualised profiling for advanced patient stratification has been rec-
ommended through the introduction of innovative patient management
by prediction, prevention and personalised treatment algorithms for this
highly specific patient cohort [4].
The predictive molecular signature in the blood of pTNBC patients has
been identified using differential molecular profiles by protein patterns of
circulating leukocytes, specific serum metabolites and subcellular imag-
ing to evaluate the quality of chrDNA. Statistically significant differences
have been demonstrated for the molecular signature of pTNBC patients
compared to those with premenopausal benignancy, premenopausal E/P-
receptor-positive BC and all postmenopausal BC. Additional stratifica-
tion by the activity level of MMP2 and MMP9 in blood serum further
improves the overall predictive power of our diagnostic approach [5]. As
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for the next stage, a large-scale validation in a multi-centre study is cur-
rently planned.
References
1. Golubnitschaja O, Debald M, Yeghiazaryan K, Kuhn W, Pešta M,
Costigliola V, Grech G. Breast cancer epidemic in the early 21st
century: Evaluation of risk factors, cumulative questionnaires and
recommendations for preventive measures Tumor Biol
2016;37(10):12941-12957. doi:10.1007/s13277-016-5168-x.
2. Vaz-Luis I, Lin NU, Keating NL, Barry WT, Winer EP, Freedman
RA. Factors Associated with Early Mortality Among Patients with
De Novo Metastatic Breast Cancer: A Population-Based Study.
Oncologist. 2017; doi:10.1634/theoncologist.2016-0369.
3. Polivka J Jr, Kralickova M, Polivka J Jr, Kaiser C, Kuhn W,
Golubnitschaja O. Mystery of the brain metastatic disease in breast
cancer patients: improved patient stratification, disease prediction
and targeted prevention on the horizon? EPMA J 2017. doi:10.
1007/s13167-017-0087-5.
4. Golubnitschaja O. Feeling cold and other underestimated symptoms in
breast cancer: anecdotes or individual profiles for advanced patient strat-
ification? EPMA J 2017;8(1),17-22. doi:10.1007/s13167-017-0086-6.
5. Golubnitschaja O, Yeghiazaryan K, Abraham JA, Schild HH,
Costigliola V, Debald D, Kuhn W. Breast Cancer Risk Assessment:
A Non-invasive Multiparametric Approach to Stratify Patients by
MMP-9 Serum Activity and RhoA Expression Patterns in
Circulating Leucocytes. Amino Acids 2017;49(2), 273-281. doi:10.
1007/s00726-016-2357-2.
Novel biomarkers predicting sensitivity to PP2A activators in triple-
negative breast cancer
Christian Saliba1, Shawn Baldacchino2, Christian Scerri3, Robert Gauci2,
Godfrey Grech2
1 Centre for Molecular Medicine and Biobanking, University of Malta
2 Laboratory of Molecular Pathology, Department of Pathology,
University of Malta, Malta
3 Department of Physiology & Biochemistry, Faculty of Medicine and
Surgery, University of Malta
*Correspondence: Prof. Godfrey Grech, Laboratory of Molecular
Pathology, Department of Pathology, University of Malta, Malta; e.mail:
godfrey.grech@um.edu.mt
Keywords: PP2A, Laser microdissection, FFPE, Predictive biomarkers,
Triple-negative breast cancer
Objective: Triple-negative breast cancer (TNBC) patients derive little
benefit from target-specific therapies due to a lack of favourable prognos-
tic targets, ER, PR and HER2. The aim of this project was to define
biomarkers to measure PP2A complex activity in breast cancer predicting
a novel therapeutic class.
Methods: A multiplex assay using branched DNA technology was used to
measure the expression of 40 genes in RNA derived from cell lines (n=12)
and formalin-fixed, paraffin-embedded (FFPE) archival material from
breast cancer patients (2009–2011). First, the PP2A activity biomarkers
(PABs) were validated in breast cancer cellular models and compared to
real-time PCR results. The QuantiGene 2.0 multiplex assay was used to
measure expression of these markers in a cohort of laser-microdissected
breast cancer (n=97) and normal breast tissue cases (n=30). Sensitivity of
cell lines to FTY720 was measured using MTT assays.
Results: Overexpression of these biomarkers in cell lines predicted sen-
sitivity to FTY720 andwere down-regulated in a dose-dependent manner.
Of interest, 37% of TNBC cases expressed high levels of PABs, and were
associated with negative prognostic indicators (P = 0.023).
Conclusion: TNBC cell lines sensitive to the PP2A activator FTY720
showed a high expression of PABs. Using patient material, PAB overex-
pression was common in the TNBC subtype. The novel biomarkers
(PABs) provide a multiplex gene expression signature for a potential
therapeutic group sensitive to PP2A activators.
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Abstract
Ageing has been associated with a great number of chronic and severe
pathologies including cardiovascular disease, neurodegenerative disor-
ders and cancer [1]. According to recent scientific reports, breast tissue
is far older than other tissues in the body [2]. Consequently, accelerated
ageing might be a specific risk factor for breast cancer development. Here
we summarise currently available facts to support this hypothesis.
Lifestyle factors involved in both accelerated ageing and breast cancer risk:
Educational level, sociodemographic and marital status; tobacco and al-
cohol consumption; sedentary lifestyle against physical activity; partici-
pation in social networks and leisure activities; workload and occupation-
al environment; nutrition and diet composition; sleep patterns [3].
Pathologies associated with both ageing and (breast) cancer
predisposition:
Overweight/obesity; chronic inflammation; diabetes mellitus; autoim-
mune diseases; endocrine dysfunction; immune dysfunction; cognitive
dysfunction; dental disorders; impaired wound healing [1,4,5].
Specific patient profiles for predictive diagnostics and targeted preventive
measures:
Genetic predisposition (inborn syndromes, symptoms and disor-
ders); specific molecular profiles (biomarker panels including
Bintrinsic epigenetic age acceleration^ profiles, CpG-methylation
patterns, detoxification pathways, DNA-repair patterns, energy bal-
ance, amongst others) in blood, saliva and urine; symptoms of the
pathologies associated with ageing (such as impaired wound
healing); lifestyle factors listed above.
The presented profiles are the subject of follow-up studies to be validated
for their practical application within innovative population screening and
educational programmes.
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Abstract
Diagnosis of breast cancer subtypes determines therapeutic options
and prognosis. These subtypes are hallmarked by the expression of
the human epidermal growth factor receptor 2, and oestrogen and
progesterone receptors (HER2, ER and PgR). An audit of breast
cancer diagnosed in Malta between 2009 and 2016 indicates that
85% were ER-positive, 11% were HER2-positive, and 10% were
negative for all receptors. Current guidelines for diagnosis of
HER2 are based on immunohistochemistry and confirmatory test-
ing by fluorescent in situ hybridisation (FISH). HER2 copy num-
ber assessment on 960 breast cancer samples (cBIOPortal [1, 2]) is
estimated to detect 1.3% amplification in the absence of expression
(false positives) and 4.2% diploid accompanied by overexpression
of the gene (false negatives).
A multiplex branched DNA assay has been validated for quantify-
ing gene expression on degraded RNA derived from formalin-
fixed paraffin-embedded (FFPE) breast cancer tissue [3]. Using
the diagnostic results as benchmark, this assay has average sensi-
tivity and specificity of 100% and 97.8% for the determination of
HER2 status and ER status, respectively. The gene expression
assay is a novel, quick multiplex method that can accurately diag-
nose breast cancer subtypes, eliminating subjectivity of interpreta-
tion and minimising technical variation. This method has a wide
range of possible applications in the diagnosis of tumours and is
adapted to the current diagnostic workflow.
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Abstract
Human epidermal growth factor receptor 2 (HER2)-positive breast
cancer cases constitute about 11% of the local breast cancer bur-
den. These patients are candidates for targeted treatment with the
anti-HER2 monoclonal antibody trastuzumab (Herceptin®,
Genentech), in conjunction with chemotherapy and hormonal ther-
apy if required, as an adjuvant or neoadjuvant to surgery in oper-
able cases. The rates of clinical response to treatment have not yet
been recorded locally. A retrospective clinical audit is thus cur-
rently in progress in collaboration with the Sir Anthony Mamo
Oncology Centre (SAMOC). All HER2-positive breast cancer pa-
tients tested between 2010 and 2016, extracted from Mater Dei
Hospital laboratory records, were included for the review of pa-
tient clinical records from their treatment history files. The follow-
ing information is being collected where available:
& Date of initial diagnosis
& Age at diagnosis
& Tumour stage and pathological grade
& Treatment regime (adjuvant, neoadjuvant or treatment for advanced
disease)
& Tumour measurements before and during/after treatment
& Date of recorded tumour progression/metastasis/new lesion
diagnosis
& Date of death in the case of deceased patients
All clinical and radiological responses are given a final assess-
ment using the Response Evaluation Criteria In Solid Tumors
(RECIST) 1.1. The findings to date will be presented and com-
pared to published findings in other countries. This audit will
allow treatment response rates to be correlated to laboratory find-
ings on archival tissue specimens in the ongoing Breast Cancer
Project at the University of Malta.
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Abstract
Background. CA 19-9 is the only approved biomarker for moni-
toring tumor response in patients with pancreatic adenocarcinoma
(PDAC), but it has several limitations, highlighting the need for
new predictive biomarkers [1]. Mutant KRAS is a driving onco-
gene, occurring in 75–95% of PDAC [2].
Aim. To develop an analysis tool based on plasma to monitor the varia-
tion in mutant KRAS alleles in PDAC being treated with first-line
chemotherapy.
Methods. Twenty-seven PDAC patients were enrolled in this
study. Six milliliters of plasma were prospectively collected at
baseline, after 15 days of chemotherapy and at each clinical fol-
low-up. CftDNA was extracted from plasma with a specific kit
and analyzed by the Droplet Digital™ PCR (ddPCR) for KRAS
mutations in codon 12 (G12X) and G13D.
Results. At baseline, 19 out of 27 patients (70.3%) were carriers
of one of the KRAS mutations. Eight patients had a negative
cftDNA mutKRAS at baseline, and one out of eight became pos-
itive at day 15, and another one at the first radiological evalua-
tion. There was a statistically significant difference in progression-
free survival (PFS) between patients with increased vs. stable/
reduced cftDNA at the 15-day sample (median PFS 2.5 vs. 7.5
months, p=0.03; see Fig. 1). A statistically significant difference
was also observed in median overall survival (OS; 6.5 vs. 11.5
months in cftDNA increase vs. reduction, respectively, p=0.009).
Conclusions. cftDNA analysis of mutKRAS could be a reliable
non-invasive approach for early prediction of tumor progression
and responsiveness to chemotherapy. However, in order to assess
these preliminary data, further analyses are needed.
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Fig. 1 PFS according to cftDNA mutKRAS variation at day 15
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Abstracts
MicroRNAs represent an emerging class of non-coding RNAs with sig-
nificant functions in the post-transcriptional regulation of gene expres-
sion. As they also regulate oncogenes and tumour-suppressive genes,
microRNAs play an important role in the process of malignant
transformation.
The aim of this study was to evaluate expression levels of selected
candidate microRNAs (miR-221, miR-143, miR-145, miR-133a,
miR-146, miR-31 and Let-7 g) in the peripheral blood of 95 lung
cancer patients and 100 matched healthy control individuals. We
used RNU48 as a reference gene. RNU48 was identified by
geNorm and NormFinder algorithms as the most appropriate for
the normalization of the microRNA expression in peripheral blood.
The expression level of miR-143 was significantly higher (p <
0.0001), whereas the expression level of miR-221 (p = 0.000253)
was significantly lower, in the blood samples of patients with lung
cancer in comparison to the control group. Based on the capacity of
these miRNAs to discriminate patient and control samples, we sug-
gest that after further validation, these microRNAs could serve as
potential non-invasive diagnostic biomarkers in lung cancer.
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Abstract
Background. In non-small cell lung cancer (NSCLC) patients, the effi-
cacy of treatment with EGFR tyrosine kinase inhibitors (EGFR-TKIs)
depends on activating EGFR mutations [1]. However, in half of cases,
inhibition of EGFR may select resistant cells displaying the EGFR
p.T790M point mutation [2].
Aim. Tomonitor the early variation in EGFRmutations in NSCLC patients
using circulating cell-free tumor DNA (cftDNA) extracted from plasma.
Methods. Seventy-nine NSCLC patients were enrolled in this ongoing
explorative study. Six milliliters of plasma was prospectively collected at
baseline and at each clinical follow-up. CftDNAwas extracted from plas-
ma with the QIAamp Circulating Nucleic Acid Kit (Qiagen®) and ana-
lyzed using the Droplet Digital PCR (ddPCR; (BioRad®) for EGFR
p.L858R, exon 19 deletions and p.T790M mutations.
Results. Forty-four patients testing positive for EGFR activating mutation
were treated with the first-generation EGFR-TKIs, while 35 patients testing
positive for p.T790M at baseline were treated with AZD9291, the potent,
irreversible EGFR-TKI selective for the p.T790Mmutation. During the treat-
ment with first-generation TKIs, nine patients experienced clinical progres-
sion after a median of 9 months and, testing positive for p.T790M, switched
therapy to AZD9291. Interestingly, the appearance of low levels of activating
EGFR mutations anticipated the appearance of both high levels of the resis-
tance mutation and clinical progression occurring several months later.
Conclusions. CftDNA analysis is useful not only for monitoring clonal
evolution of NSCL cancer cells under the stress of EGFR-TKIs, but also
in evaluating treatment responses and choosing themore effective therapy
in individual patients.
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Abstract
The availability of CTCs as liquid biopsies suggests the potential for study-
ing dynamic change(s) in CTCs during the course of therapy, thus informing
both treatment and drug development. Small cell lung cancer (SCLC) has a
poor prognosis due to rapid growth, early tumor spread, and unavoidable
drug resistance [1]. It has been suggested that the CTC number and persis-
tence in SCLC is highly prognostic, which could be of clinical utility for
guiding disease management or in early clinical trials of novel agents [2]. A
major challenge in the clinical utilization of CTCs is their rarity, and several
approaches have been taken for their enrichment, each with its limitations
and with no one clearly superior. We, therefore, developed a completely
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flexible rare-cell imaging approach that could be applied to CTCs enriched
by any desired method. Enrichment can be marker-based, size-based, or
microfluidic, or large (twomillion per slide) numbers of cells can be scanned
quickly and efficiently, requiring no enrichment. This approach was able to
detect a single tumor cell in one million peripheral blood mononuclear cells
(PBMC), with either filtration-based enrichment or no enrichment. CTCs
were identified in patients with a variety of cancers [3], utilizing both tumor-
specific antibodies and fluorescent in situ hybridization (FISH) markers for
the detection of aneuploidy. Analysis of a 2-ml blood sample from an SCLC
patient identified eight CTCs (Fig. 1). This uniquely flexible approach per-
mits the interrogation of a CTC for up to five nucleic acid or proteinmarkers,
allowing, in addition to enumeration, the molecular characteristics of the
detected CTCs to be explored.
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Abstract
Glioblastoma multiforme (GBM) represents one of the most malig-
nant tumors of the primary central nervous system in adults, with
considerably high mortality [1,2]. Standard therapies including neu-
rosurgery, radiotherapy and chemotherapy with temozolomide have
only a limited effect on the long-term survival of GBM patients
[3,4]. A number of targeted anti-cancer therapeutics, including
low-molecular-weight tyrosine kinase inhibitors or monoclonal an-
tibodies, have been evaluated in numerous clinical trials with newly
diagnosed as well as recurrent GBM. Unfortunately, until today,
only one targeted anti-tumor drug – the antiangiogenic inhibitor
bevacizumab – has been approved for the treatment of recurrent
GBM, albeit not in the EU [5]. Moreover, its effect on the overall
survival of patients with recurrent GBM remains controversial.
Major advances in cancer immunotherapy over the past few years
now offer hope for the possible future use of such treatment strate-
gies for patients with GBM as well [6,7]. This presentation will
discuss the recent preclinical and early clinical results from studies
evaluating anti-tumor immunotherapy using so-called immune
checkpoint inhibitors that might improve the very unfavorable prog-
nosis of patients with GBM in the near future. This work was sup-
ported by MH CZ – DRO (Faculty Hospital Plzen - FNPl,
00669806) and by the National Sustainability Program I (NPU I)
Nr. LO1503 provided by the Ministry of Education, Youth and
Sports of the Czech Republic, and by the Charles University
Research Fund (Progres Q39).
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Fig. 1 CTC detected in an SCLC patient based on the presence of a
DAPI-stained nucleus (top left), expression of EpCAM (bottom left),
and lack of CD45/CD31 expression (top right). A composite image of
the DAPI, EpCAM, and CD45/CD31 channels is shown at the bottom
right.
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Abstract
Most colorectal cancers are considered sporadic, and often the cause is
not known. Biomarkers of individual repair capacity (IRC) play a role not
only in the risk of developing cancer, but also in virtually every aspect of
the course of the disease.
In our case–control study of 273 colorectal cancer patients and 187
cancer-free controls, the 22 single-nucleotide polymorphisms (SNPs)
in 12 genes (GSTP1, CYP1A2, CYP1B1, CYP2C8, CYP2C9,
CYP2E1, CYP2W1*2, CYP19A, MTHFR, XRCC1, hOOG1, DPYD)
were genotyped and analyzed for their correlation with the risk of
sporadic colorectal cancer in multivariate logistic regression models.
There were significant genotype associations of the following SNPs:
rs1695 GSTP1, rs1801133 and rs1801131 MTHFR, rs25487 XRCC1
rs1052133 hOOG1 and rs1801160 and 1801159 DPYD. Haplotype
analysis of four DPYD polymorphisms showed significant differ-
ences in the distribution of the IISt haplotype between cases and
controls. In comparison to the most common haplotype (VISt), the
IISt haplotype was associated with increased risk of colorectal cancer
(p = 0.038, OR = 2.733, 95% CI = 1.019–7.326).
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Abstract
Despite recent advances in clinical and experimental colorectal cancer
(CRC) research, the optimal approach for stratifying CRC patients re-
mains uncertain. We previously described amplification of TRIB1 and
MYC in 14.5% and 7.4% of a CRC cohort (n=118), respectively, and
found these amplifications significantly correlated (p = 0.0001) in a num-
ber of cases1. Our current aims are (i) to understand the prognostic role
and function of TRIB1 in CRC, and ii) to identify a clinical and molecular
signature for this subgroup of patients that can be used for prognostication
and therapeutic targeting. To this end, we are validating TRIB1
expression/amplification in 500 Maltese patients diagnosed with CRC
between 2008 and 2011. A tissue microarray platform was used to quan-
tify gene amplification by fluorescence in situ hybridisation (FISH) and
protein expression by immunofluorescence imaging. TRIB1 expression
will be associated with several clinicopathological parameters. CRISPR/
Cas9 technology was used to create three stable TRIB1 knock-down CRC
cell lines, which were used for functional analysis using the Celigo®
image cytometer to measure cell cycle progression, proliferation, tumour
growth, and invasion. Western blotting will be used to interrogate several
pathways including MAPK, PI3K/AKT, NF-κB, cell cycle, and apopto-
sis. Our data show that Trib1 protein expression in the patient cohort is
significantly positively correlated with Akt, BRCA1, Met, Erk, Stat3,
MEK, Myc, caspase 3, PTEN, Stat3, and CDK2 (p =<0.05). These find-
ings will fully characterise the TRIB1-positive subgroup, laying the foun-
dation for therapeutic targeting and companion diagnostics. Correct pa-
tient stratification increases patient survival, reduces recurrence, and min-
imises overtreatment.
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Abstract
The increasing number of cancer cases and high cancer-related mortality is
a global problem that requires huge financial investments in both diagnos-
tics and therapeutic interventions. The most challenging issue for cancer
therapy is the development of personalized approaches. Despite recent
advances in our understanding of fundamental aspects of cancer cell biol-
ogy and the development of anti-cancer therapeutic approaches,
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accumulating evidence indicates that efficient anti-cancer personalized ther-
apy is possible only if we consider the role of the immune component of the
tumormicroenvironment in carcinogenesis (1). Another essential factor that
defines individual responses to chemotherapy is intratumoral heterogeneity.
This is caused by genomic instability in cancer cells, resulting in the selec-
tion of resistant clones that can differentially interact with the immune
component of the immune tumor microenvironment (2). Moreover, we
have recently found that compartmentalization of the immune component
in functionally different intratumoral areas is predictive of metastasis effi-
ciency after neoadjuvant chemotherapy in breast cancer patients (3).
Targeting specific immune components of the tumor microenvironment is
a promising treatment strategy that can improve the outcome of conven-
tional anti-cancer therapy. Modern immunotherapeutic approaches are
based on targeting of tumor-infiltrating immune cells, including neutro-
phils, dendritic cells, NK cells, T cells, B cells, and macrophages. The most
abundant immune cells in the tumor microenvironment are tumor-
associated macrophages (TAM) that control tumor growth, vascularisation,
and metastatic spread (4). TAM display a pronounced heterogeneity and
phenotypic plasticity that offers the possibility of using them as biomarkers
for predicting individual patient responses to therapy, and stratification of
patients towards specific therapeutic schemas. TAM intra-tumor heteroge-
neity and the existence of patient-specific phenotype signatures form the
basis for the development of novel personalized TAM-based therapeutic
approaches.
Funding: Russian Science Foundation№14-15-00350.
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Evaluation of cytotoxicity of nanoparticles on cancer cells with LDH
and MTTassays
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Abstract
Nanoparticles are gaining increasing popularity as medical tools against
cancer. Their applications range from diagnostic purposes to possible
therapeutic interventions. Although the ongoing research has revealed
some promising results, a serious manifestation of nanoparticle-induced
adverse effects has been reported by many researchers. Thus, the evalu-
ation of the cytotoxicity that nanoparticles exert on cells must be thor-
oughly examined. This study focuses on the response of two cancer cell
lines, HeLa cervical cancer and H460 lung cancer cells, to zinc oxide,
gold and silicon dioxide nanoparticles. Cells were exposed to various
doses over a 24-h period. Cytotoxicity levels were then evaluated by
MTT and LDH cytotoxic assays. Results showed reduced cell viability
over both cell lines and for all nanoparticle treatments. However, cyto-
toxicity levels varied, with correlations to dose-, nanoparticle- or cell-
dependent cytotoxicity only in specific aspects of the experiment.
Although further research is needed to reveal the full potential, alongwith
the complete range of side effects, of nanoparticles, the versatile perfor-
mance of these nanoscale materials can be a powerful tool for researchers.
Thus far, gold nanoparticles have been the most popular in the modern
face of personalisedmedicine, with applications in imaging, drug delivery
and enhancement of conventional therapeutic strategies. In addition, zinc
oxide and silica nanoparticles have been used in cancer diagnostics and
therapeutics as well as imaging and drug monitoring, applications that
make them promising candidates for individually targetedmedicine [1-5].
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Abstract
Psychiatry as a clinical discipline is largely driven by a symptom-based
approach that underpins current diagnostic (e.g. DSM-V) and therapeutic
decision-making processes. Reliable biological markers are largely absent
from current diagnosis and treatment. In addition, evaluation of treatment
efficacy rests solely on patient self-report and clinical judgement. Does
psychiatry as a field have the opportunity to develop beyond a clinically
driven Bwait-and-see^ approach [1]? In this presentation, the concept of
personalized psychiatry will be introduced, which integrates both biolog-
ical systems and clinical markers, incorporating prevention, prediction
and participation as key features of personalised medicine.
The identification of distinct clinical and biological disease trajectories un-
derscores a prospective and proactive preventive approach to mental illness
for a large proportion of people at risk for a first or for subsequent episodes
of mental illness [2,3]. Pre-treatment stratification into meaningful sub-
groups of patients is a necessary part of personalized psychiatry, in order
to inform more effective treatment decisions [4]. A specific biologically
determined clinical subgroup of patients with depressive symptomatology
consists of patients presenting with increased peripheral inflammatory
markers that may make these suitable diagnostic markers for clinical strat-
ification into specific treatment groups. In addition, the genomics of treat-
ment response to pharmacological and psychological interventions is cru-
cial for a personalized approach in psychiatry. The prospective and predic-
tive approach taken in personalized psychiatry requires bioinformatics
modelling that considers both clinical and biological markers for more
accurate prediction of disease onset and disease course, as well as prediction
of treatment needs. Using our multimodal probabilistic prediction model,
prediction of treatment needs in psychosis have been illustrated [5].
The outlined concept of personalized psychiatry as illustrated by several
examples comprehensively describes key ingredients needed for person-
alizing the diagnosis and treatment of patients with psychiatric disorders.
A clinical experimental validation process is essential and among the key
challenges in personalized psychiatry for the translation of findings into
clinical practice and guidelines and for patient participation.
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Abstract
Imaging of the retina with the help of high-resolution spectral domain
optical coherence tomography (OCT) has leveraged both clinical and
preclinical investigations of inflammatory, autoimmune and neurode-
generative processes that affect retinal tissue and the anterior part of
the visual pathway. In combination with (ultrahigh-field) MRI, a thor-
ough investigation of the entire visual pathway from the retina to the
visual cortex is feasible. Over the past 10 years, our understanding of
the pathophysiology of retinal damage, and how this relates to global
disease burden and clinical disability in neuroimmunological and neu-
rodegenerative diseases such as optic neuritis, multiple sclerosis, neu-
romyelitis optica, Susac syndrome, Parkinson’s disease, and dementias
has increased substantially. Consequently, OCT is increasingly used to
assess patients with autoimmune and neurodegenerative conditions of
the central nervous system in clinical routine, and the technique is also
implemented as an outcome tool in clinical trials investigating the vi-
sual system. In preclinical research, retinal imaging by OCT is used in
animal models to deepen our understanding of the pathophysiologic
mechanisms prevailing in these conditions. Both preclinical data and
clinical applications of retinal imaging techniques in relation to MRI
findings in various conditions will be presented, and future research
questions with regard to differential diagnosis and individualized treat-
ment approaches will be discussed.
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Abstract
Proactive healthcare relies on the capacity to detect health risk
and early disease states. The recent Institute of Medicine Report
on diagnosis has identified diagnosis as a major source of error in
the health system, even for established disease [1]. Diagnosis and
the decisions that follow rely on good judgement – often involv-
ing the assessment of probability and comparisons of predictions
over time for alternate scenarios.
Work in psychology around cognitive bias, heuristics and decision-
making show that humans are poor at these.
Even the well-trained routinely fail at assessing probability and at
predicting the outcome of even simple scenarios over time. Recognition
of these weaknesses and training against them does not fix them – we
seem unable to correct for our own biases. Indeed, it has been shown in
well-constructed experiments that our confidence rises as we are more
likely to predict the wrong outcome [2, 3].
Informatics and its machines are important in all aspects of pro-
active health care, but helping to accommodate for the way that
people think offers an important opportunity for the advancement
of predictive, preventive, personalised medicine (PPPM) [4].
Machine assistance can help people avoid likely errors and correct
for biases that will lead to a less rational outcome, but using the
way that people think in a constructive way, they can also be
used to reinforce the most appropriate interpretation and action.
Scientific medicine could be made much easier, and informatics and its
machines can help in new ways.
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Abstract
We present the case of a 53-year-old male patient who had been
suffering from symptoms of decompensated and chronified tinnitus
for 4 years [1], most likely caused by work stress. In addition, the
patient developed comorbid decompensated insomnia. Because of
potential bidirectional connections between tinnitus and sleep disor-
ders, an interdisciplinary approach to treatment was chosen. The
treatment plan we developed consisted of ten sessions of repetitive
transcranial magnetic stimulation (rTMS) for tinnitus [2], followed
by ten sessions of cognitive behavioral therapy (CBT) for tinnitus
and insomnia. We used the Tinnitus Questionnaire (TF) to assess
tinnitus severity, the Beck Depression Inventory (BDI-II) for depres-
sive symptoms, and the WHO Well-Being Index (WHO-5) for sub-
jective well-being. Improvements were achieved with regard to ev-
eryday functioning, as the patient went from decompensated and
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severe to clinically negligible TF scores, from minimal to no de-
pressive symptoms, and from just above critical to above average
well-being. Combining equipment-based and psychological ap-
proaches to treatment proved successful in this case. We con-
clude that a combination of rTMS and CBT may be considered
as an effective treatment for chronic tinnitus and comorbid
sleep disorders.
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Abstract
The aim of this paper is twofold. The first to assess the role of
comorbidity as a risk factor in predicting suicidality among pa-
tients with depressive disorders and those with comorbidity or
dual diagnosis. The second is to discuss implications for
prevention.
Within the framework of the UGD-supported project, the data
were collected from Clinical Hospital, Stip, Macedonia, during
the period January 2015 to March 2017. The sample consists of
140 patients (64% female and 36% male) aged 19–72 years. The
respondents were divided on the basis of mono and comorbid
diagnosis into four subgroups: 1) those with depressive disorder,
2) those with depressive disorder and physical illness, 3) those
with depressive disorder and another mental disorder, and 4)
those with depressive disorder, physical illness and mental dis-
order. Data were col lected using quest ionnaires about
sociodemographic data, structured interviews and medical docu-
mentation, while suicidal behavior was studied using the C-
SSRS scale [1,2]. Written informed consent was obtained from
all study participants.
The specific focus was on examining the relationship of suicidal
thoughts with gender and comorbidity, frequency and intensity, as
well as differences in preparation, trials, methods and number of
suicides. Additionally, we examined the characteristics of suicide
in 46 respondents and whether there was a difference among
groups in terms of suicidal behavior. The results are in line with
our expectations, and they show that comorbidity is a significant
factor in predicting suicidal behavior [3-5]. A detailed statistical
analysis is reported in the paper.
Although we are talking about a small sample, at the level of
absolute numbers and percentages, where comorbidity is a clinical
reality and suicides are related to the number of diagnoses, a
larger number of diagnoses leads to a greater risk of suicidal
behavior.
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Abstract
Lamotrigine is a novel antiepileptic drug metabolised by UGT
enzymes, mainly UGT1A4 [1,2] and UGT2B7 [2]. Genetic poly-
morphisms of UGTs result in different phenotypes by affecting the
expression levels or activity of individual UGT enzymes, hence
variability in drug metabolism and elimination [3,4,5]. Thus, phar-
macogenetics is extremely useful in the individualisation of
lamotrigine drug therapy. Moreover, paediatric populations with
epilepsy offer a specific challenge in dose individualisation, since
they undergo significant developmental changes from childhood to
adulthood [6]. The aim of this study was to investigate the influ-
ence of genetic polymorphisms of UGT1A4 and UGT2B7 on drug
concentration in Maltese paediatric patients with epilepsy.
Blood samples from 18 Maltese paediatric patients were collect-
ed. Genomic DNA was extracted using well-established standard
protocols. Primers were designed to span the entire coding se-
quence of the UGT1A4 and UGT2B7 genes. DNA amplification
of the specific genes was performed by PCR on the respective
patient samples. Gel electrophoresis was used to confirm that the
desired DNA fragment was obtained. The PCR products were
then purified and sequenced using the Sanger sequencing
method.
Various mutations were identified in both genes of interest, lead-
ing to amino acid changes in the majority of patients. This may
result in inter-individual variability in the pharmacokinetics of
lamotrigine.
This research will lead to improved therapeutic outcomes for paediatric
populations with epilepsy, by providing a greater understanding of the
contribution of pharmacogenetics to the individualisation of drug therapy
and development of personalised medicine.
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Abstract
Purpose: The aim of this study is to determine the effects of a physical
activity program for first-stage Alzheimer's patients with regard to cog-
nitive function, depression and quality of life.
Materials and methods: This is single-blinded randomized con-
trolled trial. The experimental group included 75 Alzheimer's pa-
tients (40 in the experimental group, 35 in the control group), as
diagnosed by physicians, who were in the moderate stage of the
disease (SMMSE score: 23-24) and who were allowed to under-
take physical activity. An information form including the partici-
pants' sociodemographic characteristics and medical history, the
Standardized Mini Mental State Examination (SMMSE), the
Quality of Life–Alzheimer’s Disease scale (QoL–AD) and Beck
Depression scale were used for data collection. Statistical analysis
was performed using SPSS 18.0 (IBM, Armonk, NY, USA).
Continuous data were presented as medians (interquartile range),
categorical data as counts and percentages. The researchers used
descriptive statistics, including numbers, percentages, means and
standard deviations.
Results: This study showed that the physical activity program
improved cognitive function, depression and quality of life
among first-stage Alzheimer's patients (p<0.05). These results
suggest that regular physical activity programs should be used
in routine practice to prevent cognitive decline and depression,
and to the improve quality of life for first-stage Alzheimer's
patients.
Conclusion: According to this study's findings, cognitive function, de-
pression and quality of life among first-stage Alzheimer's patients im-
proved as a result of a physical activity program.
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Abstract
The overall objective of the Systems Medicine of Mitochondrial
Parkinson’s Disease (SysMedPD, 2017-2021) project is to iden-
tify novel drug candidates capable of slowing the progression of
neurodegeneration in the subset of Parkinson’s disease (PD) pa-
tients with overt mitochondrial dysfunction. Multi-modal pheno-
typic characterisation of cohorts of monogenic PD patients with
overt mitochondrial dysfunction will be used as an anchor for
the discovery of two extreme cohorts of idiopathic PD patients:
with and without detectable mitochondrial dysfunction. A suite
of personalised in vitro, in vivo, and in silico models will be
generated using induced pluripotent stem cells (iPSCs) from se-
lected subjec ts and controls . An indust r ia l -qual i ty 3D
microfluidic cell culture product, specifically designed for the
culture of iPSC-derived dopaminergic neurons, will be devel-
oped for use in a morphological and bioanalytical screen for
lead compounds in order to reduce mitochondrial dysfunction.
By monitoring motor behaviour and in situ striatal neurochem-
istry at high temporal resolution, the in vivo response to lead
compounds will be characterised in humanised mouse models
with striatal transplants of iPSC-derived dopaminergic neurons
derived from PD patients. Personalised computational models
of dopaminergic neuronal metabolism and mitochondrial mor-
phology will be developed. These in silico models will be used
to accelerate drug development by prioritising pathways for
metabolomic assay optimisation, stratifying idiopathic PD pa-
tients by degree of mitochondrial dysfunction, predicting new
targets for reducing mitochondrial dysfunction and mechanistic
interpretation of in vitro and in vivo experimental results.
SysMedPD unites a highly experienced multidisciplinary consor-
tium in an ambitious project to develop and apply a systems
biomedicine approach for preclinical identification of candidate
neuroprotectants, for the estimated 1–2 million people world-
wide who suffer from PD with mitochondrial dysfunction. An
overview of the scientific rationale and main objectives of the
project shall be presented, followed by preliminary results to
date, particularly with respect to multi-scale mechanistic compu-
tational modelling of PD and the implications for systems med-
icine in other complex diseases.
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Abstract
Central serous chorioretinopathy (CSCR) is the fourth most com-
mon retinopathy, typically affecting men in the third and fourth
decades of life. The disease can be presented in acute or chronic
form and can lead to decreased visual acuity (VA). Changes most
often involve the macula, and are associated with pigment epithe-
lial and neurosensory retinal detachment. Diverse risk factors such
as the use of glucocorticoids, psychic stress, systemic hyperten-
sion, use of alcohol, and smoking have been reported in the
pathophysiology of the disease. Several precise diagnostic tools
showed that the choroidal blood flow is altered locally in the
affected eye in CSCR. Our investigations of patients with CSCR
showed that CSCR and Flammer syndrome have risk factors in
common. Patients with Flammer syndrome generally have in-
creased retinal vein pressure and elevated plasma endothelin-1
levels. This can be accompanied by choroidal hyperpermeability
and subretinal fluid accumulation. Flammer Syndrome could be a
potential risk factor for the development of CSCR. Screening for
Flammer syndrome among CSCR patients can help us to better
understand the pathophysiological process of CSCR development,
and may lead to important discoveries regarding predictive factors
for this disease.
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Abstract
Interleukin-7 receptor-alpha (IL7-Ra) is involved in homeostasis
of autoreactive T cells in multiple sclerosis (MS). Several studies
have confirmed an association between the polymorphism
rs6897932 C/T in the IL-7Ra gene and MS susceptibility. In our
study, we tried to identify a possible association between this
polymorphism and the risk of MS along with the rate of disease
progression in a Slovak population. The rs6897932 polymorphism
was detected in 219 clinically diagnosed MS patients and 218
healthy control subjects. We ascertained the Multiple Sclerosis
Severity Score (MSSS) for each patient, and based on these
scores, we chose 53 patients with rapidly progressing and 57
patients with slowly progressing disease. DNA samples were ex-
tracted from peripheral white blood cells and genotyped by PCR
and restriction analysis. We found a significantly higher frequency
of ancestral allele C in MS patients than in controls (p = 0.033).
We found no significant differences in genotype or allele frequen-
cies of SNP rs6897932 between the slow- and rapid-progression
subgroups. Allele C of rs6897932 seems to increase the risk of
MS development in a Slovak population. We did not confirm an
association between this gene polymorphism and the rate of MS
progression.
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Abstract
Ataxia is a disorder which presents with varying degrees of loss of control
of normal bodily movements. Although acquired ataxia may be encoun-
tered, it is more commonly found as a hereditary condition. Awide array
of genetic variants have been identified as the cause of each of the mul-
tiple subtypes of inherited ataxia. Although several members of a Maltese
family have been diagnosed with hereditary ataxia, little is known about
the nature of the causative variant/s. The family history suggests an X-
linked recessive pattern of inheritance. This study undertook the identifi-
cation and profiling of genetic variant/s causing this disorder in the af-
fected family members by means of next-generation sequencing using a
clinical exome panel coupled with bioinformatics analysis. The data are
presently being followed up by PCR amplification of the identified
variant/s or gene/s and subsequent Sanger sequencing of the PCR prod-
uct. Once established, efforts can be made to understand the mechanisms
underlying the causative variant/s such that a cure, or more likely a symp-
tomatic treatment, may be provided. Additionally, genetic counselling
can be provided to guide future generations of this family line with regard
to aspects of family planning.
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Abstract
Daily entities such as feeling of thirst, pain sensitivity and smell percep-
tion are generally conditioned by individual genetic set-up and post-ge-
nomic/epigenetic regulation – strongly influenced by social and environ-
mental factors. On one hand, an abnormal (substantially deviating from
the average) sense regulation is basically neglected at the standard level of
medical care. On the other hand, an accumulated knowledge in the area of
sense regulation demonstrates its relevance for development and progres-
sion of severe pathologies. For example, a significantly reduced feeling of
thirst leading to low water intake results in body dehydration that is a
well-acknowledged risk factor for breast cancer, amongst others [1].
Altered sense regulation attracts attention in both – diabetes mellitus,
leading to cascaded comorbidities [2], and Flammer syndrome, subopti-
mal health conditions relevant for several pathologies investigated [3-5]
(see Fig. 1).
Thirsty feeling
Reduced in Flammer syndrome with possible adverse health effects:
– short-term: dehydration, headache, migraine, mood disturbances,
amongst others
– long-term: association with breast cancer and aggressive metastatic
disease [1,5];
Increased in type 2 diabetes mellitus, possibly linked to fatigue, nausea,
cancer, preeclampsia, hip fractures, nephropathy, coronary heart diseases,
hypertension, venous thromboembolism, cerebral infarct
Pain sensitivity
Increased in Flammer syndrome, possibly linked to multiple sclerosis,
fibromyalgia, impaired wound healing [4];
Decreased in type 2 diabetes mellitus and linked to hypertension, neurop-
athy, impaired wound healing, amongst others
Smell perception
Increased in Flammer syndrome [4]; consequences are currently unclear
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Decreased in type 2 diabetes mellitus, possibly linked to cognitive im-
pairments and neurodegenerative processes, also reduced in Alzheimer´s
disease, Parkinson's disease and multiple sclerosis [2]
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Fig. 1 Altered sense regulation in Flammer syndrome and Diabetes
mellitus patients: opposed phenotypes are associated with completely
different pathological conditions
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Abstract
The cost of healthcare in the United States (US) is 50–100% more than
other developed countries. Indeed, one of its closest neighbors – Cuba –
achieves an average lifespan equal to the US and lower infant mortality at
one-tenth the cost.
California – nicknamed the BGolden State^ for both its
nineteenth- century gold mining and the color of its landscape –
would be ranked roughly sixth in the world by GDP. California is
frequently on the Bcutting edge^ of technology, climate change,
and social policy. However, it is somewhat schizophrenic regard-
ing healthcare.
In medical education, residents are increasingly burdened with
ensuring maximize reimbursement for hospitals rather than
lea rn ing the i r spec i f i c medica l / surg ica l spec ia l ty and
interacting with patients. Instruction on basic science and clin-
ical medicine is being supplanted with instruction on enhanc-
ing the electronic medical record (e.g. maximizing the disease
process Bcodes^ for each pat ient ) to ensure maximum
reimbursement.
Another theme in both California and the US in general is the
need for physicians to obtain advanced degrees such as the master
of business administration (MBA) in order to participate in a
healthcare organization. This highlights the difference between
administering (i.e. enforcing a system’s rules) and managing (i.e.
optimizing a system’s outcome), which is a fundamental differ-
ence between healthcare in the US and in the United Kingdom
and elsewhere.
However, the California state legislature in 2017 has introduced
the BHealthy California Act^ – a proposal for universal single-
payer healthcare coverage. In California it appears that legisla-
tors, no physicians, are playing Bcatch-up^ with the rest of the
developed world regarding healthcare!
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Abstract
The United Nations (UN) estimates that disasters have cost over 1.3
million lives since 1995: following the 2010 Haiti earthquake, 20,000
people died each day from lack of basic surgery. To improve survival,
disaster response (DR) must be on-site in 24 hours – not the current days/
weeks of DR agencies (e.g., UN and Red Cross).
Trauma and stroke centers (TSCs) evolved based on evidence that "24/7"
immediate treatment dramatically improves morbidity/mortality. Unlike
DR, TSC equipment/personnel are seamlessly integrated into healthcare
delivery/education systems. We propose that DR–like TSCs–be integrat-
ed into healthcare worldwide as disaster response centers (DRCs). A
DRC includes a mobile operating room (including a car battery-
powered CT, portable by helicopter) transported anywhere worldwide
within hours. Telemedicine allows immediate subspecialty medical/
surgical guidance; drones optimize utilization (e.g., identify the living
buried in rubble, optimize resource triage).
Disasters evoke a humanitarian suspension of political, cultural and so-
cioeconomic barriers that hinder response to other global crises. TheDRC
concept benefits from input/support by the World Federation of
Neurosurgical Societies, the American College of Surgeons, UN disaster
relief agencies, WHO emergency response, Aerospace Medical
Association, Chilean Health Ministry, among others. Initial DRC sites
are planned for Iquique (northern Chile) and Peshawar (northwest
Pakistan).
This global "mega TSC system", with its multinational staff, will
improve DR, establish global medical training standards, provide
universal research platforms, and advance healthcare in develop-
ing countries. There are political, cultural and socioeconomic ben-
efits – beyond the healthcare benefits – of integrating DR into the
ongoing global healthcare system.
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Abstract
International co-operation has begun to guide the way that science and tech-
nical skills may contribute to a new global system of health care. Indeed, the
trend in new research projects is one of working on a multidisciplinary basis.
Physicians and scientists realize that collaboration offers a more effective
approach to medical problems. Transparency in work and behaviour will
bring colleagues and patients closer together. Quality and behaviour codes
will be subject of special attention in the medical practice and of research as
well. Medical law implementation and coaching will contribute to optimal
medical working conditions. Education of health care workers will prepare
them for their important roles, supported by continued education. People are
aware of the need to care about the elements that the earth may be able to
supply. Some antibiotics may become obsolete and will need to be replaced
by other medicines. Databases must provide access to a patient’s medical
history so that treatment can be individually tailored. Personalized, predictive,
and preventive medicine is now a reality. Importantly, these efforts must all
ultimately serve humankind through equal and honest distribution of health
care to everyone.
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Abstract
The continuously changing market access landscape affects prescription and
reimbursement levels of medicines and diagnostics in PPPM. The preoccupa-
tion on the part of healthcare systemswith developing robust cost-containment
measures results in the emergence of new methods of value assessment, new
forms of price setting, new customer structures, and changes in reimbursement
and treatment guidelines. Although these changes facilitate access to existing
medicines for certain patient groups, they create substantial barriers for new
pharmaceutical, vaccine and diagnostic market entrants [2,4]. Thus, facing the
lack of incentives in the early 2000s, several large biopharmaceutical compa-
nies abandoned antibiotics research and development (R&D) and investment,
focusing instead on therapeutics in oncology and cardiology. As a
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consequence, resistance to existing medicines continued to increase, while the
number of new antibiotics receiving marketing authorization declined [1].
This study aims to identify major patient access barriers in PPPM, and to
understand how innovative companies overcome thesemarket access restric-
tions. The presenter suggests that there exist a number of ways for producers
to overcome market access barriers, for example, through early-phase con-
vergence with key stakeholders, introduction of miscellaneous risk-sharing
agreements, policy shaping, differentiating value-added services, and
Btailoring^ evidence generation to stakeholder requirements. [1,3,4].
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Abstract
Innovative technology to be implemented:
In personalized medicine, therapeutic intervention should be applied before
the disease symptoms appear. This requires highly specific and highly
sensitive biomarker arrays (BM) able to predict disease onset and therapeu-
tic response [1]. Reliable, multiparametric semi-diagnostic and/or disease-
predictive biomarker arrays are urgently needed for different diseases to
improve early diagnosis or for monitoring and improving new and existing
therapeutic strategies. The employment of biochip technologies for the
simultaneous measurement of several biomarkers (multiplex assay) is nec-
essary in biomedicine, since common assays (ELISA, Western blot, etc.)
allow only the quantification of a single analyte at nano- to picogram levels,
and are inadequate for quantifying low-abundance biomarkers in a complex
matrix such as serum, urine or saliva [2].
Aim of the institute:
The proposed project, Christian Doppler – Laboratory for Personalized
Medicine (CD-PM), is a multidisciplinary and collaborative effort
aimed at performing innovative and novel research in the field of
modern molecular diagnostics. The development and application of a
novel, highly sensitive biochip will significantly enhance knowledge
about biomarker detection in the early stage of diseases and thus their
role in predictive medicine. The thinking behind this project includes
both basic and oriented research, with a concrete commercial
application.
Application areas, examples:
The proposed unique and novel, highly sensitive technique is currently
being evaluated for the early detection of beta-cell dysfunction (diabetes
mellitus) [3]. The CD-PM will validate other biomarker candidates al-
ready identified by key researchers from our cooperative partners.
PPPM outlook:
This novel technology has the capacity to significantly improve the sen-
sitivity and specificity of existing analytical systems from femto to
attogram levels. Once the assay platform is established, it can be retooled
for nearly any diagnostic markers by replacing and optimizing the spe-
cific capture/detection conjugate, because the other components will be
universal. Peripheral biomarkers for other metabolic disorders are cur-
rently under evaluation [4].
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Abstract
Background. Antarctica is a unique place to study health conditions
under the influence of environmental factors on the organism in pure form
[1]. Medical research in Antarctica opens up new horizons of understand-
ing across a spectrum of individual health conditions under stress and
unusual environmental conditions.
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Aim. To analyze and discuss the retrospective medical data of
long-term monitoring and observations at the Ukrainian
Akademik Vernadsky Antarctica station and initial data from pro-
spective studies.
Methods.We analyzed the multi-scale information of retrospective
and prospective medical and biological studies, performed with
the participation of all 22 Ukrainian wintering expeditions, based
on surveys of over 220 men aged 20–60 years (mean age 37
years). Extensive medical examinations were carried out before
the expedition, during the selection of candidates, and after
returning, and particular functions were monitored during the en-
tire stay in Antarctica. Medical records were analyzed to investi-
gate microbiome, vascular dysfunction, hypoxia, mitochondrial
dysfunction, and genetic polymorphism (hypoxia-inducible factor
1 (HIF-1) parameters.
Results. The examinations showed multi-level symptoms of the process-
es of dysregulation and dysadaptation, especially during adaptation to the
Antarctic (1-month stay at the station) and, to a lesser extent, after
returning from an expedition toUkraine. A long stay inAntarctica evoked
adaptive reactions associated with hypoxia and mitochondrial dysfunc-
tion, determined by a set of molecular-genetic mechanisms that trigger the
expression of the corresponding genes and alter the mitochondria ultra-
structure, leading to the death of organelles, and subsequently the cells,
and are associated with pronounced oxidative stress [data in press].
Preliminary microbiome studies in the Antarctic setting have shown an
increase in fungi on the skin of expedition participants, believed to be due
to interference with local immunity and dysbiosis of the normal skin
microbiome due to stress, recycled air, and antiseptic agents [1,2]. This
region permits the study of conditions such as Flammer syndrome,
amongst many others. Preliminary analysis demonstrated changes in re-
sponses on the Flammer syndrome questionnaire [3] carried out before
and after the expedition; medical examinations showed stress
dysadaptation via alteration the thyroid, gut function, and pain sensation
[4].
Conclusions. The series of the retrospective and prospective studies dem-
onstrated the strong influence of extreme environmental factors and stress
in the absence of man-made factors on health parameters, with clearly
defined individually patterned reactions.
The translation of obtained results enables the determination of
the a Bpre-pathology^ condition for patient stratification that have
a crucial impact on the management of chronic diseases in routine
life by modifying stress-related conditions such as lifestyle, diet,
and microbiome. In addition, since the region is essentially sterile,
it permits unbiased research on the microbiome that may not be
possible elsewhere.
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Abstract
Laboratory medicine is among the essential sources of reliable clinical
information, providing the basis for objective disease/health assessment
in individuals [1]. Predictive, preventive and personalized medicine
(PPPM) emphasizes complex characteristics of health as a phenomenon
[2]. In this context of complexity, laboratory medicine should not only
significantly extend the range of tests and markers, but it should also
significantly expand the range of distinct analyses, reflecting four princi-
pal categories of factors/materials related to health as outlined previously
[3]. These principal categories comprise physical, chemical, biological
and psychosocial factors, each of which can be of an internal and external
nature. Complex clinical laboratory diagnostics/medicine should analyze
factors/materials that have a potential impact on health and/or consistently
reflect changes in health status. All data should then be interlinked with
the patient’s standard medical record in order to prepare a complex report
on his/her health/disease state in the context of PPPM (Fig. 1).
Such an extension of laboratory medicine, effectively supported by so-
phisticated information technology, will clearly represent a qualitative
leap in healthcare and, in the long term, have the potential to significantly
reduce healthcare costs through early prediction that is built on compre-
hensive, computer-assisted processing of reliable data acquired by com-
plex analysis of various factors/materials, thus significantly reducing
health deterioration in each individual.
The vision of EPMA is to build such a pilot complex clinical laboratory
dedicated to the personal health assessment of apparently healthy indi-
viduals [4].
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Abstract
Health awareness as a concept of health-related knowledge about
disease prevention and treatment remains underutilized by Russian
healthcare, whereas the English medical community demonstrates
a persistent use of communication strategies for health education
of the population. The objective was to identify communication
strategies employed by Russian and English medical websites for
health awareness development.
Material and methods. Ten official websites of English and Russian
healthcare organizations and executive bodies were analyzed. Total cor-
pus (n=78) included English (n=38) and Russian (n=40) texts.
Contextual, descriptive and qualitative analysis was performed, which
revealed 3three categories of strategies: informative, imperative, and
mixed (informative + imperative).
Results. The English corpus (EC) demonstrated all strategies employed
by the texts for the general public: informative (32%), imperative (25%),
mixed (43%). The Russian corpus (RC) demonstrated a predominant use
of informative strategies (57%) and significantly lower use of imperative
(18%) and mixed (25%) ones.
Conclusion. The proportional involvement of all strategies in EC
determines their effective contribution to the development of
health awareness; the lower use of imperative and mixed strate-
gies in RC may be an obstacle to developing health awareness in
the population.
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Abstract
Emergency and limited-resource subsets need sustainable, comprehen-
sive and reliable diagnostic approaches [1-3]. Emergency physicians with
imaging expertise can focus on further procedures, skipping time-
consuming and expensive steps [4-5].
Emergency clinical ultrasound, as an adjunct to other reliable bio-
markers, enables early predictive information, preventive manage-
ment of impending or worsening conditions, and personalized ther-
apy. Acute abdominal emergency (appendicitis, small bowel ob-
struction, gallstones, cholecystitis, aortic aneurysm), and particular-
ly acute chest disease (pleural-pericardial effusion, pneumonitis,
pleura-pulmonary consolidation), may present discordant informa-
tion between ultrasound (US) and chest-X-ray (CXR). An ongoing
study is addressing some new concepts in clinical and ultrasound
stratification of respiratory disease in 73 consecutive patients re-
ferred to the same emergency facility. Key symptoms (dyspnea,
chest pain, cough), laboratory assays (CRP, total leukocyte and neu-
trophilic counts) were considered, and the relative odds of finding
concordant or discordant US and CXR imaging in pleural effusion
and lung consolidation are displayed. In general, the predictive ac-
curacy of combined conventional non-imaging clues (symptoms and
laboratory assays) is insufficient for lung density and pleural effu-
sion. Accuracy in the detection of pleural effusion is exceedingly
Fig. 1 Four principal categories of external and internal factors and/ormaterials which extended laboratorymedicine, in the context of PPPM, should take
into consideration when assessing the health of an individual.
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higher for US (98.5 vs. 77.5), while the combined use of US and
CXR, with one and/or both procedures positive, provides greater
accuracy for lung density detection.
The implementation of a comprehensive culture of ultrasound imaging in
medical school curricula and in continuous medical education is a sus-
tainable advancement for the quality of our emergency departments and
of the mobile medical units used in rescue activity during disaster or war
crisis.
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Abstract
Background. The human blood group system is a complex protein-based
system that consists of multiple antigens, including 54 antigenswith more
than 200 different alleles for RHD alone, and 50 different RHCE alleles.
The five most important antigens from this blood group system are the D,
C/c and E/e, since they are the cause of most alloimmunity.
Aim. Blood group genotyping is the method of choice when serological
techniques cannot be used. In order to successfully use techniques such as
Fig. 1 Top, right lobar pneumonia (A: x-ray; B: US scan). Bottom, small bowel obstruction (A: CT scan, B : US scan)
EPMA Journal
PCR and DNA sequencing, one must first determine the frequency of said
blood group antigen genotypes in the Maltese population. Thus far, the
molecular transfusion group of Malta has investigated the Kidd,
Cartwright, Colton and the major RHD and RHCE antigens.
Materials and methods. Four hundred blood donor samples were en-
rolled in this study. An allele-specific oligonucleotide polymerase chain
reaction (ASO-PCR)was used to determine the presence of RhD, E and e,
while multiplex PCR was used to test for RhCc, Cartwright and Colton
genotypes. PCR RFLP was the method of choice for the Kidd genotypes.
Results. We present all current molecular data obtained thus far for the
abovementioned blood group genotypes. In brief, out of 400 donor sam-
ples studied, the incidence of RhDwas 90.75%, and 9.25%were negative
for the D antigen. The incidence of the other Rh antigens was 76.75% for
C and 73.75% for c, 25.25% for RhE and 97.75% for Rhe. The most
common phenotype in RhD-positive samples was CcDee (36.50%), and
in RhD negative it was ccdee (8%). The Colton Co(a+b-) exhibited the
highest percentage occurrence (88.23%), whilst the heterozygous form of
the phenotype, Co(a+b+) demonstrated a lower prevalence (5.88%).
Co(a-b+) was not encountered in this study. Other data from different
blood group antigens will also be presented.
Conclusion. These blood group systems have a vital role in population
genetic studies and, most importantly, in resolving medical issues in transfu-
sion practice, thus favouring the personalisation of health care in public health.
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Abstract
Kashin–Beck disease (KBD) as an endemic disorder is clinically char-
acterized by thickened and deformed joints. The etiology of KBD needs
to be determined. The present report shows epidemiological characteris-
tics of KBD via cross-sectional survey, national surveillance, case-
control study, and intervention trial. X-ray images of the right hands of
school children ages 7–12 were utilized to diagnose new KBD patients
and disease severity. The national incidence of KBD was 22.1% in 1990,
16.0% in 1995, 12.3% in 2000, 5.5% in 2005, 0.38% in 2010, and 0.18
in 2015. In a series of valleys and villages of Tibet, Qinghai, Shaanxi,
and Inner Mongolia, historical records show KBD prevalence of nearly
50%. In 2002, there were 819,666 individuals with KBD among
37,908,700 residents in endemic areas across China. By 2014, 611,187
patients out of 22,567,600 inhabitants were living in KBD-endemic
areas. Typical features of KBD include early onset, gender equality,
agricultural region, and uneven regional distribution. Epidemiological
data show that KBD is associated with multiple risk factors such as
fungal contamination of food grains, selenium deficiency, and food pro-
tein imbalance. Preventive measures include health funding in endemic
areas, food diversification, food protein consumption, selenium dietary
supplement, grain exchange, and relocation out of KBD areas.
Comprehensive measures have been implemented in the prevention of
KBD for a long period and so far a satisfactory result has been achieved.
It is entirely possible to eradicate KBD from the earth.
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Abstract
Background. Socially significant diseases have their roots in early years
of life, as consolidation of negative behavioral stereotypes begins in youth
[1].
Objective.To study the dynamics of the main risk factors (RF) in
students over six years of their training at the medical
university.
Materials and methods. Presented prospective analysis of a sample of
125 students enrolled in the first year in 2011, which was re-examined on
the sixth course [2]. Fulfilled questionnaire survey aimed at identifying
RF of type of arterial hypertension (AH)/pre-hypertensive (PH) [3], obe-
sity, smoking, hypodynamia, and irrational nutrition [4].
Results. AH was found in 4.6% of freshmen, including 7.9% of
boys and 3.4% of girls. It was recorded for 8.0% of graduates,
with 13.2% of boys and 5.7% of girls. PH with blood pressure of
130/80 to 139/89 mm Hg was detected in 6.4% of school leavers,
with 10.5% of boys and 4.6% of girls, and in 15.2% of graduates,
including 23.6% of boys and 11.4% of girls. Cases of obesity and
increased body mass index were identified in 9.0% during the
first year of study, with 12.9% of boys and 7.7% of girls, and
22.2% in the sixth year, including 41.8% of boys and 15.5% of
girls. The presence of physical inactivity was found in 14.8% of
first-year students, including 9.6% of boys and 16.6% of girls,
and id 38.8% of graduates, with 48.3% of boys and 35.5% of
girls. Poor nutrition was present in 44.6% of first-year students,
with 22.5% of boys and 52.2% of girls, and was found in 45.4%
of graduates, including 48.3% of boys and 44.4% of girls.
Conclusion. The negative dynamics of behavioral and biological
RF revealed among students during their study at university ar-
gues for early establishment of youth health examinations [5],
which must include relevant preventive educational modules [4].
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Abstract
Background. Poor sleep contributes to the development of stress [1],
which in turn is recognised as a risk factor for developing cardiovascular
(CV) pathology [2,3].
Objective. Evaluation of sleep and anxiety/depressive disorders (ADD)
of medical students based on their additional work in hospitals.
Material and methods. Forty-nine students of five or six courses of
medical faculty of StGMUwere surveyed with a questionnaire regarding
subjective sleep characteristics (Russian Somnological Centre) using the
Epworth daytime sleepiness scale, Stanford and Berlin questionnaires,
and the Hospital Anxiety and Depression Scale (HADS), in order to
determine the presence of ADD. Students were divided into two groups:
working students (23) and non-working students (26). Statistical analysis
was conducted using Microsoft Excel.
Results.Working students slept on average 6.0 ± 1,1 hours at night, and non-
working students 7.06 ± 1.2 hours. Severe/moderate daytime drowsiness was
found in 34% and 65% of students from the working group, but only 7% and
23% of the non-working group, respectively. Representation of apnea was
similar between the two groups, but the structural characteristics of sleep
quality differed significantly. The occurrence of pronounced/borderline values
of ADD for the working students were 31% and 42%, and among the non-
working group were 15% and 23%, respectively.
Conclusion. Additional work among medical students is associated with
a decline in quality of sleep and development of ADD, which are in turn
associated with reduced stress resistance. Working students must be in-
cluded in the cardiovascular risk group [4] for timely implementation of
preventive measures [5] as part of medical school student health centres.
The number of such centres in Russia has been steadily increasing.
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Abstract
Background.Modern lifestyles promote the development of atherogen-
esis [1]. Therefore, it is advisable to intensify implementation of diag-
nostic screening for early vascular ageing (VA) among young men [2].
Objective. To identify cases of increased VA in younger men in relation
to different risk factors (RF).
Material and methods. Fifty-five boys were examined at the Centre for
Student Health of StSMU as part of the project "The University – Health
Area". Analysis was performed on the occurrence of major RF and the
state of the vascular wall in terms of the cardio-ankle vascular index
(CAVI) and VA using the VaSera-1500 diagnostic software system
Fukuda Denshi, Japan).
Results. The number of boys at the 95th percentile for R-CAVI and L-
CAVI was 7.1 and 7.2, respectively. Of the 55 students, a CAVI level
equal to or greater than it appeared was found for six people for R-CAVI
(10.9%) and seven for CAVI-L 7 (12.7%). These young men differed in
VA by 40–44 years. One or more RF were found in four of seven boys
were distinguished. One student was characterised by dysfunction of
connective tissue (DCT) [3], with the presence of corresponding pheno-
type, propensity for keloid scars, history of pneumothoraces, and mitral
valve prolapse. Another young man suffered tonsillitis and pyelonephri-
tis, and a third student had no RF.
Conclusion. The introduction of angiologic screening in the process of
student examination can serve as a complement to traditional screening of
groups with cardiovascular risk factors [4,5], as early VA can occur in the
absence of other RF.
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Abstract
Iodine deficiency disorders (IDD) have been recognised as a severe pub-
lic health problem in China since the 1950s. Data recorded in the 1970s
show 370 million people, and in 1993, 720 million people, at risk of IDD.
Thirty out of 31 provinces and 1778 of 2835 counties were classified as
endemic. In 1994, universal salt iodisation (USI) was launched to control
IDD, and has achieved considerable success. As of 2005, China had
eliminated IDD nationally [1], with children’s urinary iodine above ade-
quate and goiter rate of 5%. However, since 2007, 342 new cases of
cretinism have been found in Xinjiang and other provinces [2].
Over the last decade, through the implementation of measures of surveil-
lance, investigation and evaluation, adjusting iodine content in salt and
supplying iodised oil pills or free iodized salt, and the establishment of an
IDD information system, China has maintained sustainable IDD elimina-
tion on a national basis [3]. The results of a national IDD survey in 2014
show a goiter rate of 2.6% among children’s, no deficient or excess
urinary iodine was found among children in all provinces, and the cov-
erage rate of qualified iodized salt had increased to 91.3%. No new cre-
tinism cases have emerged since 2010.
China has built a solid base of working experiences over the 20 years of
its USI programme, including a mechanism of Bgovernment leadership,
sectoral collaboration and participation^, and a strategy of Blocally appro-
priate and evidence-based iodine supplementation for various population
groups^. Evaluations have shown enormous success achieved by China’s
USI programme in meeting global and national IDD targets [4].
1. Su XH, Liu SJ, Shen HM, Zhang SB, Wei HL, Yu J, et al. National
iodine deficiency disorder surveillance: a sum up of data in2005 and
analysis. Chin J Endemiol. 2007; (26)1, 67-69. (In Chinese)
2. Li QL, Su XH, Yu J, Zhang SB, Liu P, Ji X, et al. Analysis of field
survey results for iodine deficiency disorders in high-risk areas of
China. Chin J Endemiol. 2009; 28(2),197-201. doi:10.3760/cma.j.
issn.1000-4955.2009.02.023. (In Chinese)
3. Ministry of Health of the People's Republic of China, the National
Standardization Management Committee. Criteria for elimination of
iodine deficiency disorders. GB16006-2008. Beijing: Standards
Press of China. (In Chinese)
4. Sun DJ. Review and recognition of key prevention and control issues
of national key endemic diseases. Chin J Endemiol, 2014; 33(2),
121-124. doi:10.3760/cma.j.issn.2095-4255.2014.02.002 (In
Chinese)
Challenges of screening plant extracts for therapeutic development:
lessons learned from a case in practice
Frank Heemskerk
Research& InnovationManagement Services bvba (RIMS), Bollestraat 75,
3090 Overijse, Belgium, e.mail: frank.heemskerk@telenet.be; T = +32 16
47 4092 (office), +32 47 999 4336 (mobile), skype <frankheemskerk>
Abstract
Natural extracts (plant metabolites, fungi, micro-organisms, etc.) are an
extremely rich and diverse source of active therapeutic ingredients, or at
the very least, contribute to preventive health and well-being. A majority
of our current therapeutics are based on an original natural discovery or
are still derived from natural sources. New medicine development is
becoming prohibitively expensive, especially for chronic and rare dis-
eases, and now, even for common viral and bacterial infections, (multi-)-
drug resistance is a widely occurring problem.
Global traditional medicine has maintained centuries of knowledge about
effective healing with these extracts. Large collections of plants and extracts
withmetabolites have beenwell-characterized, often with traditional use, but
beyond initial scientific interest, nothing is done with this knowledge base.
Fig. 1 Surveillance and investigation of IDD in China
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However, there are serious challenges to upscaling of production,
including quality control concerns and inconsistent clinical evi-
dence, posing difficulties in regulatory registration and obtaining
market authorization. Lessons learned will be presented from an
actual r ich R&D program that we performed in a bio-
pharmaceutical company to screen for and further clinically develop
a therapy against leishmaniasis.
In fact, Research & InnovationManagement Services (RIMS) is now one
of three founding organizations of a new legal entity behind a European
research infrastructure platform for natural extract screening with re-
nowned institutes across Europe (www.euplantcropp.eu), for
applications in medicine and nutraceuticals (protecting people) and
agro-biotech (protecting plants). With this new structured approach, and
with the most modern technologies through an European platform, an
open discussion with EPMA members on potential targets (and indica-
tions for which diseases) would be valuable.
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Abstract
The Mediterranean diet has been associated with a reduced risk of devel-
oping major chronic diseases and with mortality [1]. Late evidence sug-
gests, however, that people from Mediterranean areas are drifting away
from this traditional diet, and has revealed emerging socioeconomic dis-
parities in dietary habits even in epidemiological settings characterized by
a relatively high socioeconomic homogeneity [2]. In this context, the
economic crisis that started about 10 years ago poses a serious threat that
the disparities in access to healthy foods will continue to grow. The
decline in the Mediterranean diet began long ago, but a dramatic drop-
off has been recorded in the most recent years. Data from the Moli-sani
study showed that, beginning in 2007, material resources such as house-
hold income have become a strong determinant of the adherence to the
Mediterranean diet, whereas they were not associated with diet in earlier
years [3]. Although the shift was documented among the whole popula-
tion, the decline is likely to be more evident across vulnerable groups and
the elderly.
Indeed, evidence from a recent Italian national survey (INHES
study) revealed that undesirable dietary modifications possibly
linked to the current economic crisis were mainly reported by
lower socioeconomic groups, and that subjects perceiving a neg-
ative impact of the recession on their diet also showed lower
adherence to the Mediterranean diet and reduced quality of gro-
cery products.
In light of this, a fruitful reasoning on the ways to revitalize the
Mediterranean diet should necessarily deal with two key issues:
First, the Mediterranean diet has become socioeconomically patterned,
as had already been established for other quality eating models in non-
Mediterranean settings, and the prominent role of financial over cul-
tural resources in determining the adherence to this pattern should be
taken into account. Second, the current economic crisis represents a
major health threat for the general population, but in particular for the
most vulnerable socioeconomic groups, possibly leading to wider gaps
in terms of risk/protective factors across groups.
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Abstract
The mystery of longevity is attracting particular interest in the area of bio-
medical sciences. Why do some populations live longer and healthier than
others (see Fig. 1)? Ageing as the antipode to longevity is known as the main
risk factor for chronic/severe disorders such as impaired wound healing,
cardiovascular disease, cognitive pathologies, cancer, type 2 diabetes mellitus
and comorbidities with particularly poor outcomes (e.g. cancer patients with
diabetic history [1]). Is it possible to slow ageing processes and consequently
prevent the cascade of related pathologies? In order to reply to the question, it
is crucial to understand which specific mechanisms are characteristic of lon-
gevity in contrast to accelerated ageing.
Accelerated ageing – definition
Rapidly decreasing capacity of the human body to effectively defend
against internal and external damagers (extensive oxidative stress), lead-
ing to clinical onset of the age-related chronic pathologies
Longevity – definition
Stable capacity to effectively defend against damagers, remaining in ex-
cellent physical and mental health condition over plenty of life-decades
Potential biomarker panels for longevity include markers of lipidome
(APOE, LPO, CETP), oxidation protection (FOXO3A, SOD, HSP70),
genetic stability (parp, telomeres), and inflammation (IIS-system,
DHEAS, SIRT1) [2].
Individualised patient profiles
Longevity: intact genetic information, mitochondrial stability, active re-
productive function, efficient detoxification pathways, competent DNA-
repair machinery, amongst others
Accelerated ageing: genomic instability, telomere attrition, mitochondrial
dysfunction, cellular senescence, intercellular communication failure, im-
paired metabolic pathway [3]
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Fig. 1 Centenarian/longevity map. Centenarian rate (CR) – number of people who survived to 100 years per 10000 persons alive at 60 years in the
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PPPM IN DIABETES MELLITUS
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Abstract
The global epidemic of obesity and type 2 diabetes mellitus remains a press-
ing challenge for the scientific community and health care professionals (1).
Chronic low-grade inflammation is believed to contribute significantly to the
pathogenesis of target organ dysfunction/injury (e.g., nephropathy) in these
conditions (1). Lifestyle interventions (e.g., diet and physical activity) are
known to exert beneficial effects on glycemic control and general health in
obese/type 2 diabetic individuals (2). Nonetheless, standard exercise programs
are strenuous and time-consuming, and thus have low long-term compliance.
In recent years, there has been a surge of interest in whole-body vibration
(WBV) as a preventive and/or interventional modality that can be applied to
populations at risk of obesity/type 2 diabetes and associated sequelae. Indeed,
utilizing the db/db mouse model of obesity/type 2 diabetes, we recently
showed beneficial effects of WBV on glycemic status in association with
changes in several indices of inflammatory response, suggestive of a reduction
in inflammation (3). Importantly, skewing toward myeloid cell production is
often observed in chronic inflammation and autoimmune diseases (4). In this
context, myeloid-to-lymphoid skewing is defined by an increased number of
granulocyte/macrophage lineage, associated with a decrease in the frequency
of cells with lymphoid lineage. Thus, our recent studies examined the impact
of WBV in db/db mice and their db/m controls in the context of assessing
changes in myeloid and lymphoid cells in the blood, bone marrow, and
kidney. The results indicate increased myeloid potential associated with
obesity/type 2 diabetes and a developmental skewing in favor of myeloid
precursors in diabetic bone marrow. Importantly, WBV altered myeloid
skewing in blood, kidney, and bone marrow of db/db mice suggestive of
anti-inflammatory effects. Collectively, our observations are consistent with
the immunomodulatory capability ofWBV. Thus,WBVoffers the promise of
curtailing inflammation associated with obesity/type 2 diabetes, thereby pos-
itively influencing the outcome of these disorders.
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Abstract
The rising prevalence of metabolic syndrome (MetS), a cluster of cardiomet-
abolic risk factors predictive of type 2 diabetes, relates largely to increasing
obesity and sedentary lifestyle, but also to early metabolic life events. The
objective of the study was to build predictive models of evolution toward
MetS 8 years later, and to bring new knowledge about this pathological state
using a multilevel approach in an at-risk population (subjects with low birth
weight). A case–control study (subjects free from MetS at baseline (n=92
born small vs. n=76 born adequate for gestational age) was designed within
the French community-based Haguenau cohort. Serum signatures were de-
termined and compared at baseline (age 20 years) to determine predictive
biomarkers using both un-targeted metabolomics and targeted proteomics.
Individual predictive models were first built using linear logistic regressions
from the omics datasets and epidemiological data. All data were then inte-
grated to determine whether multidimensional models improved prediction.
Univariate statistical analyses enabled the identification of 93 discriminant
metabolites and 37 proteins between cases and controls at baseline, with
gender differences. The resulting models based on either four metabolites or
four proteins showed good performance: 18% misclassification (19% cross-
validation error rate) vs. 11%misclassification (19%cross-validation), respec-
tively. Multi-omic data integration improved the performance and robustness
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of the prediction (9% misclassification, 16% cross-validation). Correlation
analyses also contributed to a better understanding of the role of these bio-
markers in the pathological processes. These results should provide new tools
for better stratification of at-risk populations. This project was supported by
the Fondation Francophone de Recherche sur le Diabète.
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Abstract
Metabolic syndrome (MetS) is defined by a cluster of cardiometabolic
factors including obesity, hypertension, dysglycemia, and dyslipidemia. It
affects a growing number of persons, in particular older adults often
suffering from multiple chronic diseases, and its prevalence is now a
public health challenge. In the context of personalizedmedicine/nutrition,
new tools are necessary to bring additional knowledge about MetS etiol-
ogy, better stratify populations, and customize strategies for prevention.
A nested case–control study on MetS was designed within the Quebec
Longitudinal Study on Nutrition and Successful Aging (NuAge). It in-
cludes 61 cases and 62 controls of similar age (68–82 years), selected
among the 853 men. Both targeted and un-targeted metabolomic/
lipidomic approaches, available within the MetaboHUB French infra-
structure [1], will be performed on serum samples collected at recruitment
during 2003–2005 (T1) and 3 years later (T4). Data analysis will be
performed using reproducible online Galaxy workflows [2].
The metabolomic/lipidomic data will be processed to identify specific
signatures of MetS and its components, and to study their stability over
time. These data will then be analysed for evaluation of a molecular
reclassification of the MetS phenotype. Finally, they will be integrated
with available phenotypic and detailed nutritional data in order to better
characterize sub-phenotypes (Fig. 1).
The approach developed here will open a door for a more compre-
hensive understanding of the metabolic phenotype resulting from the
complex interplay between intrinsic and extrinsic factors. Thus, this
project will allow an improved description of MetS-associated char-
acteristics and will offer new tools for better patient stratification in
elderly populations.
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Fig. 1 Description of the overall study strategy.
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Abstract
Cardiovascular diseases are the main reason for morbidity and mor-
tality in diabetic patients, and cardiovascular risk is increased at least
twofold in men and at least fourfold in women with diabetes com-
pared to non-diabetic populations. Predictive medicine is of the ut-
most importance in the clinical care of diabetic patients, since
predicting cardiovascular risk is essential for modification of risk
factors aimed at prevention or delay of future cardiovascular events.
The prediction of cardiovascular risk is a valuable tool within the
context of patient-centered care, as it includes active participation
of diabetic patients in the decision-making process, resulting in
higher compliance with the treatments agreed. However, there are
differences among the current guidelines of various international au-
thorities, such as the International Diabetes Federation (IDF),
European Society of Cardiology (ESC) / European Association for
Study of Diabetes (EASD), American College of Cardiology (ACC) /
American Heart Association (AHA), American Diabetes Association
(ADA), and National Institute for Health and Care Excellence
(NICE), for the prediction of cardiovascular risk in diabetic patients.
Furthermore, the clinical use of models with classic risk factors and
novel biomarkers that would predict cardiovascular risk in diabetic
patients from various populations with acceptable precision poses a
challenge. Taking into consideration the global diabetes pandemic
and its close association with cardiovascular diseases, there is an
urgent need for streamlining of current guidelines on the prediction
of cardiovascular risk and its use in clinical practice.
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Abstract
Vitamin D plays a pivotal role in functional processes that control immune
function andmineral metabolism, as well as several chronic conditions [1, 2].
Emerging data indicate a possible influence of vitamin D on glucose homeo-
stasis [3, 4, 5]. This study sought to provide initial information on vitamin D
status among a Ghanaian population with type 2 diabetes and its association
with glucose homeostasis. This case–control studywas conducted among 118
patients with clinically diagnosed type 2 diabetes mellitus (T2DM) attending
diabetic clinic at the Nkawie Government Hospital between October and
December 2015. One hundred healthy non-diabetics living in Nkawie district
were selected as controls. Questionnaires were administered to obtain
sociodemographic data. Venous blood samples were taken from both cases
and controls to estimate their fasting blood glucose (FBG) and lipid profile by
spectrophotometry and iPTH and 25(OH)D by enzyme-linked immunosor-
bent assay (ELISA). Statistical analyses were performed using SPSS 20.0
software. The average age of the study participants was 58.81 years for cases
and 57.79 year for controls. Vitamin D deficiency was found in 92.4% of
T2DM cases and 60.2% of the non-diabetic controls. Vitamin D deficiency
was not significantly associated with HOMA-β [T2DM: r2 = 0.0209, p =
0.1338 and Control: r2 = 0.0213, p = 0.2703] and HOMA-IR [T2DM: r2 =
0.0233, p= 0.1132 andControl: r2 = 0.0214, p=0.2690] in either the controls
or cases. These results show that vitamin D deficiency was prevalent in both
those with and without T2DM. There was no association between vitamin D
deficiency and insulin resistance among our study population. However,
vitamin D supplementation in T2DM patients is recommended.
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Cardiol. 2010;106(7):963-8. doi:10.1016/j.amjcard.2010.05.027.
4. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of
calcium and vitamin D supplementation on blood glucose and markers
of inflammation in nondiabetic adults. DiabetesCare. 2007;30(4):980-6.
5. Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin
resistance in patients with type 2 diabetes. Diabetol Metab Syndr.
2013;5(1):8. doi:10.1186/1758-5996-5-8.
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Abstract
In resent years, plasma homocysteine (Hcy) level has been reported to be
associated with vascular complications for patients with type 2 diabetes
mellitus (DM2). In such patients, elevated Hcy levels were associated
with insulin resistance and nephropathy.
Objective
To investigate the association of hyperhomocysteinemia with macro- and
microvascular complications in patients with DM2 in a Macedonian
population.
Materials and methods
In this study, 80 DM2 patients were enrolled for study and were classified
into two groups: 30 patients with no associated complications (control),
and 50 patients with complications, with diagnosed CAD. and with
microalbuminuria. Homocysteine levels and HbA1c were determined in
both investigated groups.
Results
Hcy levels were significantly higher (p<0.000) in DM2 with complica-
tions, CAD (p<0.000), and patients with microalbuminuria (p<0.000)
compared with controls. There was a positive correlation between elevat-
ed HbA1c (r = 0.475) levels and Hcy concentration in DM2 patients.
Conclusion
The results show that homocysteine levelswere higher in patientswithmicro-
or macrovascular complications, and they were strongly positive correlated
with HbA1c. The results also reveal that hyperhomocysteinemia is a risk
factor in the etiology of vascular complications in DM2 patients.
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Abstract
Introduction. It is scientifically proven that pregnant women with
diabetes mellitus have a high risk of developing periodontal dis-
eases, but prevention and treatment is difficult in this group of
patients.
Objective: To investigate and analyze dental status of pregnant women
with diabetes mellitus, to estimate the effect of individual oral hygiene
complex on periodontal tissues in this group of patients.
Materials and methods: A clinical and laboratory examination of the
oral cavity was carried out among110 patients with different types
of diabetes mellitus and those without it. Women were randomly
separated into three groups depending on the proposed complex of
individual oral hygiene. Patients of groups 1 and 2 were trained in
cleaning teeth and using extra oral hygiene products. The first group
used toothpaste with herbal extracts; the second group used tooth-
paste with herbal extracts, sodium bicarbonate and sodium fluoride.
The third group continued oral care as always. After 2 weeks the
results were evaluated.
Results. The study revealed a correlation between values of dental
indices in these groups of patients. The highest intensity of caries,
values of hygiene and periodontal indices were found in women
with diabetes, especially with type 2 diabetes (TDI: 17.5%, OHI-
S: 1.67%, PMA: 37.4%). The proposed complexes of individual oral
hygiene demonstrated their effectiveness in groups 1 and 2.
Conclusion: The results of the study dictate a need for developing
schemes of individual oral hygiene complex based on the results
of a full dental examination, including clinical and laboratory
research.
Fig. 1 Biochemical and physiological relationship between insulin resistance, T2DM and vitamin D
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Abstract
Transcription factor NF-κB plays a key role in inflammation and is
also an important regulator of genes involved in coagulation and
thrombosis. NF-κB is activated by a number of signaling pathways
that converge, in the majority of cases, at the level of IκB kinase 2
(IKK2). Our study uses constitutive active IKK2 (caIKK2) in a
conditional transgene mouse model to mimic chronic inflammation
specifically in endothelial cells and to test a potential aggravating
impact on the onset of atherosclerosis.
Mice bearing inducible, aortic-EC-specific Cre recombinase on an
ApoE-deficient background were crossed with a strain expressing
caIKK2 downstream of a loxP-flanked stop cassette and fed a
cholesterol-rich high-fat diet for 12 weeks. RNA sequencing analysis
of the aortic transcriptome was performed 10 days after induction of
Cre recombinase by tamoxifen, before starting the western-type diet,
and revealed activation of inflammatory networks (involving TNF,
IFNγ and IL1β), which were accompanied by increased immune cell
infiltration. Flow cytometric analysis of lymph nodes and splenic
tissue was used to detect infiltration and activation of B and T cells.
In summary, we conclude that endothelial NF-κB signaling orches-
trates immune cell responses within the arterial wall and therefore
plays an important role in the pathogenesis of atherosclerosis.
Furthermore, our data indicate that inflammatory endothelial cell ac-
tivation causes early B-cell and T-cell responses in the pathogenesis
of atherosclerosis before the occurrence of cholesterol-rich lesions.
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Abstract
Objective: This study aimed to evaluate the relationship between the
target sequence SNPs in a 3′ untranslated region (3′ UTR) of the
NOTCHI1 gene and susceptibility to congenital heart disease (CHD),
and to explore the functional role of the NOTCHI1 gene in CHD.
Methods: Functional SNPs in a NOTCH1 target sequence were screened
using bioinformatics databases. A case–control study of 350 children
with CHD and 430 controls was conducted to analyse the association
between rs6563 SNPs and CHDs. NOTCH1 mild and mutant recombi-
nant expression vectors were constructed by a luciferase reporter gene
EPMA Journal
system. The effects of relevant miRNA on gene regulatory effects were
also analysed.
Results: The allelic or genotypic distributions at the locus of rs6563
showed statistically significant susceptibility to CHD (odds ratio [OR] =
1.502, 95% CI: 1.209–1.866, P<0.001). Compared to subjects of G/G
genotype, individuals with G/A or A/A genotype showed the ORs of
1.414 (95% CI: 1.047–1.908, P=0.02) and 2.366 (95% CI: 1.430–3.914,
P<0.001), respectively. miR-3691-3p reduced the luciferase activity of the
A allele, but had no effect on the activity of the G allele. This result
indicates that the mutation from G to A enhances the negative regulation
of miR-3691-3p to NOTCH1, contributing to the development of CHD.
Conclusions: The polymorphism of rs6563G>A is related to hereditary
susceptibility to CHD. The mutation of G>A may affect the regulation of
miR-3691-3p to the NOTCH1 gene and alter CHD susceptibility.
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Fig. 1 RNA-Seq analysis was performed 10 days after induction of gene expression in aortas of BMX caIKK2mice. Clustering of cell type-specific genes using
Ingenuity Pathway Analysis (IPA) revealed massive infiltration of T lymphocytes, macrophages, and B lymphocytes. Also depicted are the number of genes in
each cell type (A). To get a better molecular understanding of the effect of caIKK2 in ECs, IPAwas used to identify canonical pathways (B). BMX caIKK2 KI
mice were crossed on APOE-deficient background and treated with a western-type diet for 12 weeks. En face preparation of isolated aortas revealed increased
plaque areas in caIKK2KImice (C). Draining lymph nodes of the aortas of caIKK2KImice showed increased percentages of CD3+CD4+ andB220+ cells (D).
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Abstract
Background:Obstructive sleep apnea (OSA) is a sleep disorder character-
ized by complete or partial upper airflow cessation during sleep, which is
reported to affect approximately 17% of American adults [1-3]. Although it
has been widely accepted that OSA is a risk factor for the development of
hypertension, studies focusing on this topic have revealed inconsistent re-
sults [2-4]. We aimed to clarify the association between OSA and hyper-
tension, including essential and medication-resistant hypertension.
Methods: The Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) was followed [5]. PubMed and Embase databases were
used to search for relevant studies published up to December 31, 2016. A
quantitative approach using meta-analysis was employed to estimate the
pooled odds ratio (OR) and 95% confidence interval (CI).
Results: Twenty-six studies with a total of 51,623 participants (28, 314male/
23, 309 female; mean age 51.8 years) met the inclusion criteria and were
included in this study. Among these, six studies showed a significant associ-
ation between OSA and resistant hypertension (pooled OR = 2.842, 95% CI
= 1.703–3.980, P<0.05). In addition, a combination of 20 original studies on
the association betweenOSA and essential hypertension presented significant
results, with pooled ORs of 1.184 (95% CI = 1.093–1.274, P<0.05) for mild
OSA, 1.316 (95% CI: 1.197–1.433, P<0.05) for moderate OSA and 1.561
(95% CI: 1.287–1.835, P<0.05) for severe OSA.
Conclusions: Our findings indicated that OSA is related to an increased risk
of resistant hypertension.Mild, moderate and severe OSA are associated with
essential hypertension, which manifests a dose–response relationship. The
associations are stronger among whites and male OSA patients.
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Abstract
Introduction: Cold extremities (cold hypersensitivity in the hands
and feet, CE) is a common symptom in East Asia, including Korea
[1, 2]. In Korean medicine, CE is used for pattern identification and
is believed to be associated with various symptoms and diseases [3,
4]. This study aimed to investigate whether quality of life (QOL)
differs depending on the presence or absence of CE.
Methods: In 2013, a national survey was conducted among the general
population through a specialized survey institute. Subjects were selected
randomly using a multistage stratified sampling method based on distri-
bution by region, gender, and age (95% confidence level, sample error ±
3.0%). A total of 1101 subjects aged 20–84 years were asked to complete
a questionnaire evaluating QOL (SF-12) and the extent of cold extremi-
ties [5]. Multiple regression analysis was used to evaluate the correlation
between CE and QOL score, with adjustment for age, gender, and body
mass index (BMI).
Results: Among participants, 18.6% (n = 208) demonstrated CE and
72.7% (n = 800) no CE. CE was more prevalent in women than men,
and those with warm hands and feet had higher BMI than those with cold
hands and feet, regardless of gender or age. In multiple regression anal-
ysis, CE showed a significant independent effect on the SF-12 physical
component summary (β = −0.11, p < 0.001) and mental component
summary (β = −0.10, p < 0.01) when we adjusted for gender, age, and
BMI.
Conclusion: This study showed that CE demonstrated significant inde-
pendent effects on health-related QOL indicators.
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Abstract
Background. Pregnancy can function as a load test for identifying
women at high cardiovascular (CV) risk [1]. Improvement is
needed in the system of preclinical diagnosis of CV disorders in
pregnants [2].
Objective. To assess the significance of the parameters of central
aortic pressure (CAP) and aortic pulse wave in the overall cardiac
examination of pregnants with respect to preeclampsia (PE).
Material and methods. A total of 253 pregnant women were surveyed,
in whom risk factors and CV activity was evaluated using the BPLab
diagnostic complex (Petr Telegin, Russia) with Vasotens Office software
[3]. A comparison of central and peripheral pressure made it possible to
identify various options for hypertension (H) – hidden, false and system-
ic. The results were processed using Statistica 8.0 software.
Results. The occurrence of false H was seen in 2.75%, systemic H in
2.75%, and hidden H in 7.5% of cases. The augmentation index in
women with hidden H did not differ from those with systemic H.
The incidence of PE in normotensive women was 0.9%, with sys-
temic H in 14.3% and hidden H in 10.5%. In patients with false H,
such cases were generally not encountered.
Conclusion. The data indicate the feasibility of including an assessment
of CAP in CV examination protocols for pregnants [4,5]: first, the high
prognostic value of this index was confirmed, and second, hidden AG
was discovered more frequently in pregnant women than systemic and
false forms of pressure buildup. The significance of this problem is evi-
denced by the increased aortic rigidity and more frequent development of
PE.
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Fig. 1 Multiple regression analysis for the association between cold extremities and QOL
Model 1: unadjusted. Model 2: adjusted for gender and age. Model 3: adjusted for gender, age, body mass index. B, unstandardized regression
coefficients; SE, standard error of unstandardized coefficients; β, standardized regression coefficients; QOL, quality of life; PCS, SF-12 Physical
Component Summary; MCS, SF-12 Mental Component Summary. *** p < 0.001; ** p < 0.01
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Abstract
Studies are lacking as to whether somatoform vegetative nervous
system dysfunction (SVNSD) is a premorbid condition for cardiovas-
cular disease (CVD). The present study involved 259 patients with
SVNSD and CVD risk factors (RF), mean age 22.8 ± 1.6 years.
Dispersion mapping of the electrocardiogram was used. A factor
analysis was carried out using the principal components method.
The criterion for the adequacy of the Kaiser-Meier-Olkin sample
was 0.664. The Bartlett sphericity criterion was (χ2 (45) = 826.555,
p <0.001). Three factors with proper values greater than 1 were ex-
tracted. The first factor (F1) – metabolic – combined systolic blood
pressure 0.866, diastolic arterial pressure 0.871, and excess body
weight and obesity 0.792. The second factor (F2) – psychoemotional
– combined psychosocial stress 0.855, anxiety 0.827, and depression
0.868. The third factor (F3) – the prenozological changes in the elec-
trophysiological state of the myocardium (EPhSM) – combined the
variables: office heart rate 0.820; the total value of the dispersion
deviations from the norm after an exercise load of 0.434. The dura-
tion of RRNN after 4 minutes of orthostasis was −0.869; the total
value of the dispersion deviations from the norm after 4 minutes of
orthostasis was 0.576. Factor analysis made it possible to establish
biopsychosocial interrelationships among the psychosocial, biologi-
cal RF of the CVD and the EPhSM.
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Abstract
Background. It is well known that a standard lipid profile measures total
cholesterol, triglycerides, and HDL cholesterol (HDL-c), while LDL cho-
lesterol is estimated. Subtracting HDL-c from total cholesterol, we can
measure the amount of cholesterol carried by all lipoproteins except
HDL. This simple math will give the amount of non-HDL cholesterol
(non-HDL-c) within all atherogenic lipoproteins. However, although it is
so easy, biochemical laboratories rarely report the value of non-HDL-c.
Aim of the study. The aim of our study is to highlight the results of several
studies that clearly establish the clinical use of non–HDL cholesterol as a
common predictor of blood lipid patterns associated with increased risk of
heart disease.
Material. Recent literary evidence and clinical studies.
Results. The most important document regarding non-HDL-c was deliv-
ered by the National Cholesterol Education Program Adult Treatment
Panel III, where non–HDL-c was highlighted as a key secondary goal of
therapy in lipid treatment and lipoprotein management. Other studies sug-
gest that non-HDL-c shows a better correlation with small dense LDL
particles than do other lipid parameters, including LDL-c. The treatment
goal for non-HDL-c is usually 30mg/dL above the LDL-c treatment target.
Conclusion. Knowing that non–HDL-c is superior to LDL-c for the pre-
diction of cardiovascular events, it is very important for each clinical
chemistry laboratory to report non–HDL-c as a part of routine lipid status,
with no added expense. Doctors could use it for optimal prevention of
atherosclerosis and cardiovascular disease.
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Abstract
Introduction: Hypertensive nephropathy (HN) is a medical condition
characterized by damage to the kidney due to chronic high blood pressure,
and it is second common cause of end-stage renal disease. Podocytopathies
have a role in pathogenesis of HN, thus the podocyte proteins may have
significance in early detection of disease. The purpose of this paper is to test
the significance of nephrin as a marker for early detection of HN.
Material and methods: This study included 64 people with chronic hy-
pertension (CH; 33 male/31 female) with an average age of 54.1 ± 5.1
years. Thirty healthy subjects (10 male/20 female) with an average age of
48.7 ± 9.4 years were included as a control group. All patients were divided
into three groups: patients with normoalbuminuria, microalbuminuria and
macroalbuminuria, according to urinary microalbumin/creatinine ratios. As
material, we used fresh urine and venous blood. In urine we measured
nephrin by the ELISA method, creatinine photometrically and
microalbumin turbidimetrically. In blood we measured urea, creatinine,
albumin and total protein using a photometric method.
Results: In 69.7% of normoalbuminuric subjects with CH, we found
elevated urinary nephrin. Nephrin was significantly elevated in all groups
of participants with HN compared with the control group (p<0.05).
Nephrin was significantly elevated in patients with normoalbuminuria
compared with the control group (p<0.05). We found a positive correla-
tion between urinary concentration of nephrin and serum creatinine and a
negative correlation between urinary nephrin and eGFR.
Conclusion: Nephrin can be a useful marker for early and non-invasive
detection of HN.
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Abstract
The scientific literature suggests that tear biomarkers can be used as a
guide towards clinical diagnosis of human health [1]. This study will
investigate whether tear biomarkers represent a research and clinical op-
portunity to assess human health prior to, during, and after exposure to the
spaceflight environment. The focus of this study is to compare bio-
markers previously identified as potentially relevant to both ocular and
brain health against unique physiological outcomes of exposure to the
spaceflight environment.
Study subjects suffering from terrestrial conditions thought to be similar
to spaceflight-associated neuro-ocular syndrome (SANS: formerly VIIP),
e.g. patients with idiopathic intracranial hypertension (IIH) and optic
neuritis, may be relevant to conditions associated with spaceflight. This
study will review methodologies, tear biomarkers related to the state of
ocular and brain health, and the strengths and weakness of using tear fluid
biomarkers versus other body fluid samples, and will survey current tear
fluid biomarker knowledge in research and clinical practice.
A strength of using tear biomarkers is that sampling is non-invasive and is
used as a guide in understanding pathologies, including ocular and sys-
temic inflammatory conditions [2]. Moreover, tear biomarkers may re-
flect diseases affecting the central nervous system (CNS) [3]. For exam-
ple, in multiple sclerosis (MS), the concordance rate between tear bio-
markers and cerebrospinal fluid (CSF) is approximately 83%, indicating
that in the majority of cases, tears are at least as effective as CSF in
potentially identifying novel MS biomarkers [4].
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Abstract
Impression cytology (IC) is a method which has been used to assess ocular
surface cells from patients, e.g. conjunctival and corneal epithelial cells. IC is
a minimally invasive technique which utilises biopore, cellulose acetate or
polyethersulfone (PES) filters to sample cells, and has traditionally been used
to ascertain morphological changes to aid in the diagnosis of squamous
metaplasia and dry eye disease (DED).1,2
More recently, IC has been utilised for the investigation of gene expression
of ocular surface cells.3 We demonstrate the use of IC to identify gene and
protein expression changes between DED subjects and healthy controls
(HC).
Conjunctival epithelial cells from DED patients (n=8) and HC (n=7) were
harvested by IC using the Eyeprim™ device. Quantitative PCR (qPCR) was
performed to quantify differences in target gene expression: p38-α, IL-1β,
IL-8, MCP-1 and MMP-9. In addition, the spatial localisation of proteins
p38-α and phospho p38 were probed in immunofluorescence assays.
Using the Eyeprim device, the average yield of conjunctival epithelial cells
(CEC) retrieved was 1.1 x 105 cells/mm2. qPCR analysis demonstrated sig-
nificantly higher p38-α, IL-1β, IL-8, MCP-1 (all p<0.0001) and MMP-9
(p<0.002) expression in CE from DED patients versus HC.
Immunofluorescence studies significantly increased p38-α and phospho
p38-α protein levels in DED subjects versus HC (p<0.0001 and p<0.01,
respectively).
As IC retrieval procedures have improved and the sensitivity of detection
has increased,4 gene and protein analysis of IC-retrieved CEC may be
used to identify novel biomarkers of ocular surface diseases.
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Fig 1. H & E staining of normal human conjunctival cells following IC (Eyeprim® membrane), where (A) shows overall coverage with normal human
conjunctival cells and (B) shows the magnified structure of conjunctival cells.
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Abstract
Omics and systems biology have driven the rapid development of predic-
tive, preventive, and personalized medicine (PPPM). Variations exist in
the entire process of healthcare. Extensive genomic, transcriptomic,
peptidomic, proteomic, and metabolomic data have been achieved in
the field of human omics. Of these, proteomic variations are the final
presentation of the genomic and transcriptomic variations. Metabolomic
variations are the comprehensive results originating from proteins,
nucleic acids, sugars, and lipids. Proteins and metabolites are two essen-
tial elements to differentiate the phenotypes. Moreover, many aspects in
the proteome including splicing, post-translational modifications, trans-
location, conformation, redistributions, and variants, and in metabolome
including entire component of metabolites, pattern variations, and
disease-specific metabolomic variations, remain unknown. Clarification
of variations in the phenome is a key step toward realizing PPPM prac-
tice. Proteome and metabolome are important components that contribute
to the phenome. Therefore, studies of variations in proteomes and
metabolomes have important scientific value in PPPM, including resolu-
tion of disease molecular mechanisms, determination of effective and
reliable biomarkers for personalized prediction/prevention, diagnosis/
therapy, and prognostic assessment, and discovery of effective therapeutic
targets to achieve precision medicine.
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Abstract
IgG N-glycan profiles can serve as dynamic indicators of the
ageing process and are able to discriminate between normal and
accelerated ageing by highlighting a discrepancy between a
body’s age in years of life (chronological age) and its age in
terms of health status (biological age). Therefore, IgG N-
glycome represents a real-time indicator of the interaction be-
tween genetic/epigenetic predisposition and the environment. IgG
N-glycans serve as predictive biomarkers when health is evaluated
in the context of age, based on the proposition that specific IgG
N-glycans i) identify variations in responses to maturation, age-
ing, and environment across the life course at a population level;
ii) facilitate early risk prediction of chronic disease development;
and iii) serve as prognostic indicators for the benefit of targeted
preventive and disease treatment interventions. A new challenge,
the ability to develop an Bageing biomarker kit^ to be used in a
(pre)clinical setting as a tool of predictive, preventive and
personalised medicine, is presented here.
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Abstract
Nondegradable metallic and polymeric implants are used as mainstream
solutions in regenerative medicine. Chronic inflammation is the most
common complication leading to implant intolerance and failure. Key
cells that control local inflammation and foreign body response are tissue
macrophages (1). After implantation, macrophages induce acute inflam-
matory reactions to trauma and foreign material, which must be followed
by the resolution of inflammation, wound healing phase and restoration
of homeostasis. Personalized therapeutic solutions are required to im-
prove implant integration and acceptance.Macrophages are highly plastic
cells that define the reactions of the immediate tissue microenvironment
to the implanted material. However, frustrated phagocytosis and inability
of macrophages to resolve inflammation and restore tissue-specific ho-
meostatic balance can lead to the chronic inflammation around implants.
The prevention of implant-induced chronic inflammation by program-
ming of the macrophage phenotype is a promising strategy for improving
implant acceptance. The aims of such programming include controlling
the phenotype of local macrophages by long-term fixation of their healing
activities and suppression of inflammatory reactions. We have developed
a cytokine cocktail formula (M2Ct) that induces a stable M2-type pheno-
type in human primarymacrophages characterized by significant suppres-
sion of induced pro-inflammatory reactions and increased secretion of
anti-inflammatory cytokines (M2Ct) (2). The positive effect of the
M2Ct was demonstrated in an in vitro wound healing model. Using this
model for induction of inflammation by LPS, we demonstrated that the
M2Ct phenotype was stable for at least 12 days. However, in the absence
of M2Ct components in the medium, macrophages underwent rapid pro-
inflammatory reprogramming upon IFNg stimulation. In order to over-
come the plasticity of macrophages and stabilize their phenotype, for
direct application of this cocktail on implants and in tissue engineering
in vivo, the loading and release of the cytokine cocktail from a self-
standing, transferable gelatin/tyraminated hyaluronic acid based release
system was developed. The cytokine cocktail demonstrated its anti-
inflammatory activity in controlled-release conditions. Our data suggest
that the direct application of a potent M2-inducing cytokine cocktail in a
transferable release system can be used as a personalized solution to
improve the long-term acceptance of implanted materials.
Funding: EU FP7 for research and technological development and dem-
onstration (Grant number 606294, IMMODGEL).
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Abstract
Main phases of the physiologic wound healing (WH) are the Bearly
wound^ (hemostasis characterised by fibrin clot formation, bleeding stop-
page and creation of the hypoxic microenvironment) followed by the
inflammatory phase well controlled by the wound healing mechanisms.
That proceeds into the Blate wound^ featuring the proliferative phase
comprising stem cell recruitment, angiogenesis/neovascularisation and
wound contraction, followed by tissue remodelling and scar formation,
finalising the physiologic WH [1].
Major players in the physiologic WH are the cellular stakeholders oper-
ating the repair processes, namely platelets, DECTs, neutrophils, macro-
phages, T lymphocytes, fibroblasts, myofibroblasts, keratinocytes, epi-
thelial cells, endothelial cells, endothelial progenitor cells, stem cells,
peripheral neurons, and extracellular matrix [2].
Potential biomarker panels includes growth factors (PDFGF, VEGF,
TGF-ß, FGF protein core, EGF, IGF), cytokines/chemokines and tran-
scription factors (IL-1, IL-6, TNF-α, IL-10, IL-4, IL-13, SDF-1α, HIF-1),
neuropeptides (substance P, NGF, NPY, CGRP), matrix-proteases/inhib-
itors (MMPs/TIMPs), hormones and nutrients, amongst others [3, 4].
Impaired WH leads to post-surgical complications frequently observed in
the elderly, chronic ulcers in diabetic patients, hindered and ineffective
pain management, etc. However, these well-acknowledged examples are
just the Btip of the iceberg^. The entire spectrum of potential conse-
quences of the impaired WH is much mor broader, further extended by
the chronic inflammation and cell/tissue transformation processes causing
tissue dysfunction and calcification as well as (neuro)degeneration, pro-
gressive formation of pre/cancerous lesions and pre-metastatic niches.
That is a subject for predictive diagnostics, targeted prevention and
personalised medical approaches [5].
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Abstract
Physiologic wound healing (WH) is a well-controlled, highly orchestrated
process involved in numerous ordinary (sporadic finger cut during meal
preparation, regular manicure, etc.) and extraordinary (e.g. acute or planned
surgery) conditions. WH is life-important. Physiologic WH is initiated by
tissue injury and resolved within a reasonable time frame by the restoration
of tissue integrity. The entire process follows the essential sequence of
attributed phases: hemostasis, inflammation, proliferation, and tissue re-
modelling (Fig. 1) [1]. In contrast, impaired WH is characterised by low
quality of phase-performance, stagnation (such as chronic inflammation),
prolongedWHprocess or even non-healingwounds [2]. The quality ofWH
is highly individual, resulting from both non-modifiable (genetic predispo-
sition, age) and modifiable (e.g. nutrition, lifestyle, preventable collateral
pathologies such as type 2 diabetes) risk factors. Contextually, the quality of
WH is considered n essential parameter in individualised patient profiling
and the subject for advanced approaches by systems medicine, predictive
diagnostics, targeted preventive measures, and treatments tailored to the
person – altogether innovative approaches by predictive, preventive and
personalised medicine as the Bmedicine of the future^. For that, multi-
level diagnostics utilising comprehensive biomarker panels is proposed.
The potential application is multifaceted: early diagnosis of related pathol-
ogies and disease predisposition, effective prevention and treatment of col-
lateral pathologies, prediction and prognosis of post-surgical complications,
improved individual outcomes in plastic surgery, amongst others [3].
References
1. Mathieu D, Linke JC, Wattel F. Non-healing wounds. In: Mathieu D,
editor. Handbook on hyperbaric medicine. Dordrecht: Springer
Netherlands; 2006. p. 401–28.
2. Demidova-Rice TN, Hamblin MR, Herman IM. Acute and impaired
wound healing: pathophysiology and current methods for drug de-
livery, part 1: normal and chronic wounds: biology, causes, and ap-
proaches to care. Adv Skin Wound Care. 2012;25(7):304–14.
3. Avishai E, Yeghiazaryan K, Golubnitschaja O. Impaired wound
healing: facts and hypotheses for multi-professional considerations
in predictive, preventive and personalised medicine. EPMA J.
2017;8(1), 23-33. doi:10.1007/s13167-017-0081-y
Fig. 1 The process of WH is characterised by an essential sequence of attributed phases; however, the quality of WH is highly individual
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Abstract
Multi-omics of saliva is garnering exponentially increasing attention
as a preferred non-invasive diagnostic tool considered for a spec-
trum of health conditions, with strong potential for clinical utility.
However, the association between specific patient profile and saliva
components (omics signature) should be well understood [1]. Due to
the complexity of its components deriving from different sources,
whole saliva is particularly attractive for the biomarker set-up,
reflecting systematic diseases such as cancer and metabolic syn-
drome [2,3]. The use of saliva for early and predictive diagnostics
demonstrates many advantages, such as simple collection, which
can be easily performed by non-specialised medical units or even
by patients at home. Saliva collection is a non-invasive approach, in
contrast to drawing blood or biopsies; it is inexpensive and presents
no potential health adverse effects typical for any invasive sampling
and/or radiological approaches utilised for molecular profiling such
as magnetic resonance spectroscopy [4].
Multi-omics of saliva is a diagnostic tool based on the proteome,
transcriptome, micro-RNA, metabolome, and microbiome, which is
utilised in many biomedical fields. Recent advances have broadened
the salivary diagnostic approach from the oral cavity to the whole
physiological system, and thus point towards a promising future of
salivary diagnostics for personalized individual medicine applica-
tions, including clinical decisions and post-treatment outcome pre-
diction [5].
Biomarker panels created for specific diagnostic purposes include
markers of periodontitis (SNPs), smoking (NGAL, CF058), oral carcino-
mas (TSCC), orthodontically induced inflammatory root resorption
(DMP1, DSP, DPP), pancreatic cancer (KRAS, MBD3L2, ACRV,
DPM1), and gastric cancer (CSTB, CSTB, CSTB) [1-5].
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Abstract
The problem of endoscopic hemostasis merits a special place in the treat-
ment of gastroduodenal bleeding [1].
We conducted a pilot study in 27 dogs, in which we caused two
bleeding stomach ulcers in each animal (one was pilot, the other
was control). In 15 pilot ulcers, hemostasis was performed with
Asepticob-D insufflations in combination with Zhelplastan. In 12
pilot ulcers the bleeding was stopped with Asepticob-A and
platelet-rich plasma [2]. Endoscopic treatment of the control ul-
cers was not exposed. The results of the study were evaluated
according to the following criteria: hemostasis time, re-hemor-
rhages, defects healing time.
The experiments showed that in the pilot ulcers, hemostasis occurred in
3.92 ± 0.32 s (p<0.01). However, there were no re-hemorrhages. In the
control ulcers, spontaneous bleeding occurred in 27.46 ± 1.12 s (p<0.01),
and there were four episodes of re-hemorrhage. The pilot ulcers were
healed in 8. 6± 0.18 days (p<0.01), the controls in 15.50 ± 0.31days
(p<0.01).
Conclusion: Granular sorbents in combination with hemostatic agents
perform three functions: permanent hemostasis, re-hemorrhage preven-
tion, reparative regeneration acceleration.
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Abstract
The problem of symptomatic erosive or ulcerative gastroduodenal bleed-
ing in patients with therapeutic pathology is very relevant now [1].
We developed a curative program for prevention of gastroduodenal bleeding in
patients with therapeutic pathology. This program is based on a multidisciplin-
ary approach, diagnostic algorithm improvement, early preclinical endoscopic
diagnosis on the second to third day, and well-timed administration of innova-
tive technologies in local preventive treatment of symptomatic gastroduodenal
erosions and ulcers with biologically active granular sorbents. A total of 144
patientswith somatic pathologywere involved in the clinical study.Thepatients
were treated in a multi-field inpatient department and had signs of acute ero-
sions and gastroduodenal ulcers. Clinical observations showed that early diag-
nosis by therapeutic endoscopy helped to reveal acute gastroduodenal erosions
and ulcerswithout bleeding in 70.7%of patients (p<0.05). Thewell-timed local
treatment of acute gastroduodenal erosions and ulcers with the help of biolog-
ically active granular sorbents enabled the prevention of hemorrhagic compli-
cations and extra operations, with threefold lower mortality.
Reference
1. E.F. Cherednikov, A.A. Kunin, E. E. Cherednikov, N.S. Moiseeva. The
Role of Etiopathogenetic Aspects in Prediction and Prevention of
Discontinuous-Hemorrhagic (Mallory-Weiss) Syndrome. EPMA J, 2016.
Application of thermal imaging for personalized diagnosis of
lipodystrophy
Joanna Bauer1*, Ewelina Dereń1, Agnieszka Migasiewicz2, Halina
Podbielska1
1Department of Biomedical Engineering, Faculty of Fundamental
Problems of Technology, Wrocław University of Science and
Technology, Wrocław, Poland
2Department of Cosmetology, Faculty of Physiotherapy, Wrocław
University School of Physical Education, Wrocław, Poland
*Correspondence:Prof. Dr. Halina Podbielska, Department of Biomedical
Engineering, Faculty of Fundamental Problems of Technology, Wrocław
University of Science and Technology, 50-370 Wrocław, Wybrzeże
Wyspiańskiego 27, Poland E-mail: halina.podbielska@pwr.edu.pl
Keywords: Infrared thermography, Thermographic analysis, Skin
imperfection, Cellulite
Abstract
Lipodystrophy or panniculopathy (edematous fibrosclerotic panniculopathy),
often called cellulite, is a dimpling appearance of the skin that can lower
quality of life in many individuals, especially the female populations.
Reliable and objective diagnosis of the stage (degree) of panniculopathy is
difficult, sincemethods such as theNürnberger-Müller or Elson scales are not
very accurate and are subjective. The more advanced techniques such as
high-frequency ultrasonography, ultrasound elastography or photometric
measurements are also not well adapted for diagnosing this skin condition.
We propose exploiting thermal imaging for cellulite diagnosis and mon-
itoring of anti-cellulite therapy. The superficial skin temperature is influ-
enced by many factors, among them changes in the microcirculation, as
well as uneven fat cell and water distribution.
The study was performed using a database of 100 thermal images of female
volunteers, aged 19–22, with different stages of cellulite, first diagnosed by
the Nürnberger-Müller scale. The study was conducted with the approval of
the Senate Ethics Committee for Scientific Research at the University School
of Physical Education in Wrocław. All recommendations of the European
Association of Thermology for thermographic measurements in medical ap-
plications, including preparation of the attendees, exclusion criteria, environ-
mental conditions and imaging system operational requirements, were strictly
followed. A thermal image of the back thigh of each volunteer was recorded
using a FLIR T335 thermographic camera.Next, all thermal images were
analyzed using software specially developed by our group, called
ThermaAnalyzer 2.0. This software allows one to determine the number
and total area of skin irregularities, as well as the distribution in the examined
region of interest (ROI). Asymmetrical and inhomogeneous superficial tem-
perature distribution, seen as spots of different sizes and shapes on the thermal
image, was observed in persons suffering from cellulite. Using quantitative
parameters including total area of the blemishes and the extent of the area of
irregularities on the thermal image enabled diagnosis of the cellulite stagewith
more than 80% accuracy. Thus, computer-aided thermal imaging analysis
provides an objective method of diagnosis and monitoring of therapy results.
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Abstract
Cardiotocography (CTG) is used during pregnancy to monitor fetal well-
being. It enables early detection of fetal distress by monitoring the fetal
heartbeat along with uterine contractions. More advanced systems record
fetal movements as well. Diagnosis by means of CTG is usually per-
formed only in the third trimester, mainly in stationary health care centers
(hospitals, ambulatory units or well-equipped private practices). Thus,
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pregnant women are required to travel to the corresponding location, and
wait for the test and then the diagnosis.
In the case of high-risk pregnancy, CTG is a very useful diagnostics tool.
An abnormal CTG indicates serious abnormalities, and in late pregnancy
may lead to emergency caesarian section. However, even in low-risk preg-
nancy, it gives the comfort of the proper fetal care what undoubtedly influ-
ences a well-being of a future mother. There are some attempts to allow the
in situ CTG diagnosis without the necessity to visit health care unit.
Here, we report on an innovative integrated device based on amicroprocessor
and a dedicated operating system for in-home use by pregnant women.GSM/
GPRS/3G-based communication enables a territorially almost unlimitedCTG
signal transfer from the woman to the telecare center.
The pregnant woman is instructed by the doctor or nurse on how to use
the device and how to transmit the recordings. She then receives the
recorded signals in the form of diagrams, alongwith explanations relating
to the fetal heart rate, fetal movements, mother's HR, and warning of (if
present) decelerations, signal variability, etc. She is also instructed what to
do, and in the case of emergency, she can be transferred to the nearest
hospital as quickly as possible.
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Fig. 1 Exemplary CTG diagrams received by pregnant women after sending the recorded signals to the telemonitoring center
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Abstract
Clinical dentistry continues to rely heavily on traditional restorative ap-
proaches and biomaterials to treat/replace damaged and diseased teeth
and the periodontium. More recently, implant dentistry has also made
major strides in techniques for replacement of missing teeth.
Importantly, the recognition of the pivotal role of stem cells in tissue
repair and regeneration has led to intense research to identify tooth-
derived stem cells. Studies have subsequently shown not only the ability
of tooth-derived stem cells to generate various components of the tooth
and periodontal structures, but also their utility in regenerative medicine,
as exemplified by the generation of cells of organs such as the heart, liver
and brain. More recent studies have demonstrated (functional) tooth re-
generation in animal models that display physical properties seemingly
similar to those of natural teeth. Even more exciting is the advent of
induced pluripotent stem cells (iPSCs) which, similar to embryonic stem
cells, have the hallmark feature of differentiation to cells of the three germ
layers; iPSCs make it feasible to generate epithelial and mesenchymal
stem cells for eventual in vitro generation of a tooth bud, followed by
implantation into the tooth socket. Since the creation of iPSCs requires
the use of somatic cells, investigators have explored the possibility of
using integration-free human urine-induced pluripotent stem cells for
tooth regeneration. Clearly, this approach has the potential to ultimately
lead to Bcustom-making^ of tooth and supporting structures, thereby
bringing true meaning to the term Bpersonalized dentistry .^ Other highly
relevant research areas involve the identification of growth factors and
delivery options as well as scaffolding material that would be most con-
ducive to tooth regeneration. These aspects and their relevance to PPPM
are the focus of this presentation.
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Abstract
Objectives. We hypothesized was that differences in culture and oral
health care system in Estonia and Vietnam might have an impact on
dental health (dmft+DMFT) and dental fear and anxiety (DFA) in chil-
dren of the two countries. The aim of this study was to compare dental
fear and anxiety (DFA) in relation to dental health between Estonian and
Vietnamese schoolchildren using the modified Dental Subscale of the
Children's Fear Survey Schedule (MCFSS-DS).
Methods. Among a total of 900 schoolchildren 8 to 10 years of age, 344
from Estonia and 556 from Vietnam agreed to participate in this study.
Dental healthwas recorded based on dental caries experience index ofmixed
dentition (dmft+DMFT). DFA was measured using the MCFSS-DS with
five Likert-scale response options (1 = not afraid at all, 5 = very afraid).
Results. The mean dmft+DMFT score in Estonian and Vietnamese
schoolchildren was 5.2 ± 3.1 and 4.1 ± 3.2, respectively. The mean score
of 11 fear items amongVietnamese children (20.8 ± 9.1) was significantly
higher than that of Estonian children (15.4 ± 4.4). The prevalence of high
DFA in Estonian schoolchildren (30.7%) was statistical equivalent to that
of Vietnamese schoolchildren (28.0%, p>0.05).
Conclusion. There were significant differences in DFA between Estonian
and Vietnamese schoolchildren. Differences in oral health care systems
between the two countries might be considered as a factor affecting dental
health and DFA among schoolchildren.
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Abstract
Relevance. The success of dental treatment depends both on the profes-
sionalism of the dentist and on the patient’s compliance with the doctor’s
medical recommendations [1]. One of the important factors of compli-
ance is the attitude of patients toward their own dental health [2,3].
Methods. The study involved 136 people aged 18 to 60 years. Methods of
diagnosis: "Health Attitude" by R.A. Berezovskaya, Questionnaire on the
relationship to dental health.
Results. Among respondents, 34% defined "dental health" as a good
physical or mental health, and 16% as a lack of disease. Most patients
assessed their dental health as an average of 63.5 points out of 100, while
75% of respondents indicated that they needed dental treatment.
Respondents aged 30–39 years (67 points) rated their health the best. A
total of 37%of respondents noted that they did not visit the dentist because
of high prices for services, and 21% because they were afraid of dentists.
Respondents noted that in health, they relied more on the opinions of
doctors and less on the media. Among patients, 42% across different ages
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preferred the empathic, non-referential type of doctor. A doctor of this type
listens to the patient, builds partnerships, and discusses treatment strate-
gies with the patient. Most patients (65%) preferred a female dentist.
Findings. The majority of respondents noted that dental health was im-
portant and they needed treatment, but they postponed it. Patients pre-
ferred a doctor who discussed the course of treatment.
Conclusion. The study revealed the need to develop a plan for individual
approaches for patients of different age groups.
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Abstract In this article, the psychological characteristics of dental pa-
tients with periodontal disease are summarized, along with a description
of patients with positive and negative dynamics of treatment.
Objective: To identify relationships between the characteristics of a pa-
tient’s personality and their implementation of dentist recommendations.
Materials and methods: Forty-five patients were surveyed, with an average
age of 43 years. The following psycho-diagnostic methods were used: 1) a
multidimensional questionnaire on health; 2) the "Diagnosis of interperson-
al relationships" test; 3) Questionnaire characterological Leonhard–
Shmishek; 4) individual-typological questionnaire Sobchik L.N.; 5) ques-
tionnaire of self-evaluation status; and 6) Behterevsky Institute Personality
Inventory. The following dental indexes of oral health were measured: 1)
CPITN, 2) PMA, 3) Saxer–Muhlemann, 4) Silness–Loe, and 5) OHI-S.
Results: Based on the results of two measurements of the dental
indexes, three groups of patients were identified: 1) those with
good oral hygiene, 2) those with poor hygiene and positive dy-
namics (improving dental health index), and 3) those with poor
hygiene and negative dynamics (deterioration indexes). A relation-
ship was found between dentist recommendations and patient per-
sonal characteristics.
Summary: Most patients tried to follow the doctor's recommenda-
tions for oral care, as evidenced by the decline in dental health
indices in the second survey. Differences in patient personal char-
acteristics, whether patients did or did not follow recommendations,
and gender differences were found between groups with improve-
ment and deterioration indexes.
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Abstract
Nowadays, the science of dental materials is intently focused on
the creation of "ideal" filling material. The research carried out at
the Dentistry Department of Voronezh State Medical University
was motivated by the need to improve the properties of filling
materials under the influence of an electromagnetic field to en-
hance their physical and mechanical properties and to prevent den-
tal complications.
It is well known that fillingmaterials used for dental caries prevention and
treatment consist of various components, including synthetic polymers,
which play an important role in forming the main structure of these
materials as well as in their physical and chemical properties.
Scanning electron microscopy (SEM) was used to study the properties of
polymeric restorative materials before and after their exposure to the
electromagnetic field in vivo, including a study of microstructural char-
acteristics of filling materials.
The SEM results confirmed the significant changes in the microstructure
of polymeric restorative materials under the influence of an electromag-
netic field, i.e. an improvement in their mechanical properties.
Analysis of the data indicates the presence of microstructural changes in
the physical and mechanical properties of filling materials after the elec-
tromagnetic field exposure, namely increased strength under compres-
sion, diametrical fracture and bending.
These findings may contribute to increasing the service life of filling
materials and preventing the occurrence of secondary caries, thus
positively affecting the quality of treatment on the whole.
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Abstract
A number of authors consider rational oral hygiene an integral component
of etiopathogenetic prevention of dental caries and periodontal disease.
For in vitro studies and the evaluation of physical and chemical proper-
ties, the structure and substructure of 30 toothpaste samples were exam-
ined using a Libra 120 transmission electron microscope (ZEISS) with
different techniques: fast electron diffraction, and bright-field and dark-
field imaging. In vivo studies included clinical assessment of the state of
hard dental tissues after the application of ROCS Sensitive Instant Relief
toothpaste during the month before and after electromagnetic field
exposure.
The in vitro results revealed certain changes in the microstructure of the
ROCS Sensitive Instant Relief toothpaste after electromagnetic field ex-
posure consisting of compound particle enlargement and corresponding
changes in density.
According to the in vivo results, a reliable positive effect after the application of
therapeutic toothpaste was achieved in 98% of cases. However, when it was
exposed to the electromagnetic field, a greater anti-caries effect was observed,
which was confirmed by numerous diagnostic techniques.
Thus, as a result of the application of ROCS Sensitive Instant Relief
toothpaste in the study group, the mean value of the dental hygiene index
was reduced from 0.80 ± 0.06 to 0.50 ± 0.02 towards an improvement in
oral hygiene status. The cariogenicity of dental plaque disappeared in
most patients of the study group, which was confirmed by the statistical
data, from 40.4 ± 2.53% before to 13.73 ± 1.82% after. There was no
significant reduction in the control group indices.
The studies thus revealed certain changes in the microstructure of ROCS
Sensitive Instant Relief toothpaste caused by the electromagnetic field
and in the ion-exchange processes in hard dental tissues during their
use, which leads to a significant increase in their therapeutic and prophy-
lactic efficacy.
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Abstract The development of practical skills using simulation training
eliminates the risk to patient’s health and life, provides a personalized
approach to learning and the possibility of developing practical skills
and bringing them to automatism, and ensures the objective control of
the quality of their execution.
Objective: to determine the effectiveness of a simulation method of
teaching manual skills when handling removable dentures in a clinical
setting.
Methods: The first phase of the study involved 82 third-year students,
divided into a control group where the training was conducted with the
use of standard phantoms, and a study group that used a fifth-generation
CDS 100 dental simulator. The second phase included 48 young special-
ists who had participated in the first phase, and were divided into groups
similar to those of the first phase. The quality of the preparation for the
both stages was objectively assessed with a Zirkozahn S600 ARTI
scanner.
Results: In the control group, the main reason for the need for additional
correction of the abutment teeth at both stages was inadequacy of the
dental ledge, with an ANOVA factor indicator of 1.1 for the first phase
and of 1.15 for the second, which indicates statistical identity of predic-
tors in this group. The study group found no statistically significant dif-
ference between the quality of the dental ledges executed at the first and
second stages of the study, with an ANOVA factor indicator of 0.9, which
indicates the statistical significance of such a predictor for preliminary
acquisition of automatic movements acquired while working with the
simulator.
Conclusion: The use of the CDS 100 interactive dental simulator pro-
vides a higher level of practical skills development and, most significant-
ly, their "survival" compared with the classical form of education, which
is confirmed by subsequent clinical practice.
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Abstract
The scientific data proving that enamel is a mineral and protein tissue
with a system of microcirculation in the form of enamel tubules served as
the basis for this study. The orifices of the enamel tubules open onto the
enamel surface. The dental pulp fluid rushes out through enamel and
dentinal canals because of the pressure gradient in the pulp. The chewing
function is the only physiological mechanism to provide the pressure
gradient.
The aim of the study was to evaluate the functional state of superficially
localizedmasseter and temporalmuscles in adolescents aged 13–16 yearswith
high and medium caries resistance, by means of electromyography.
Electromyography was conducted to evaluate the masseter and temporal
muscles in 62 adolescents aged 13–16. The assessment was carried out
using the Synapsis apparatus. The degree of tooth caries development
was determined by intraoral roentgen diagnostics using the de Götzen
S.r.l. electrometric diagnostics dental apparatus and light-induced
diagnostics.
The electrobiological activity of the masseter muscles was found to be
significantly lower in patients with medium caries resistance than in ad-
olescents with high caries resistance. There was an imbalance between the
electrobiological activity indices in the masseter and temporal muscles;
an increase in masseter fatigue in response to a static load in adolescents
with medium caries resistance was observed. That situation may lead to a
reduced pressure gradient of the dental pulp fluid in the pulp cavity, its
failure to enter enamel tubules, and consequently to lower enamel resis-
tance, with the risk of a cariogenic situation in adolescents.
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Objective. According to a number of authors, low-intensity laser
radiation contributes to a significant increase in the resistance of
enamel to caries. The development of new methods of prevention
with the use of physiotherapy, and the resulting decrease in the
volume of medical measures and material costs, is highly relevant.
The main purpose of this study is to assess the effectiveness of
preventive measures to achieve an anticaries effect using MRL
physiotherapy with the Svetozar device.
Materials and methods. The Svetozar laser and photomedicine de-
vice (wavelength, 628 nm; radiation width, 10 nm; pulse frequen-
cy modulation, 76 Hz; wide interval pulses; radiation power, 6
mW) was used. Caries preventive measures were carried out in
30 patients aged 18 years. The teeth were dried and covered with
fluoride varnish, and were then subjected to irradiation with the
Svetozar for 2 min per tooth. The preventive measures were per-
formed within 5 days, and the course was repeated in 6 months.
Efficiency monitoring was carried out before and after treatment
using acidic enamel biopsy according to V.K. Leontiev and the
tooth plaque cariogenicity (TPC) evaluation.
Results. Preventive therapy resulted in a 43% reduction in the rate
of acid solubility of enamel and a 54.8% decrease if combined
with fluoride varnish. The use of MRL resulted in 82.5% com-
plete elimination of TPC.
Conclusion. MRL plays an important role in caries prevention in
adults, as it has a pronounced anti-caries effect on tooth enamel.
If it is combined with fluoride varnish, it is possible to achieve a
71.5% reduction in the growth of dental caries.
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Bacterial pollution of air is associated with the existence of proinflamma-
tory infections in surgical patients and the use of dental equipment dis-
persing bacterial aerosols of the oral cavity during orthopedic and thera-
peutic treatment.
Objective: Scientific justification of the principles of cross infection pre-
vention in dental care facilities.
Materials and methods: We studied the material obtained in bac-
teriological studies of 2160 air samples taken in dental rooms of
different profiles, in winter and in summer, in the city and in the
countryside.
Results: The beginning of a working day is characterized by different
levels of bacterial pollution of air in dental rooms of different profiles
(surgical – 779 CFU/m3, therapeutic – 1702 CFU/m3, orthopedic – 1942
CFU/m3). In the middle of a working day, bacterial pollution increases
(surgical – 2075 CFU/m3, therapeutic and orthopedic – 2525 CFU/m3).
At the end of a working day, the bacterial pollution rate is the highest
(surgical – 2623 CFU/m3, therapeutic – 3701 CFU/m3, orthopedic – 3709
CFU/m3).
Bacterial pollution in dental rooms differs between summer and winter.
At the beginning of a working day, the summer indices are higher than
those of winter (winter – 1702 CFU/m3, summer – 2188 CFU/m3). In the
middle of a working day, the summer indices are also higher (winter –
2525 CFU/m3, summer – 2963 CFU/m3). At the end of a working day,
however, the winter indices are higher (winter – 3701 CFU/m3, summer –
3098 CFU/m3).
Bacterial pollution in dental rooms differs between the city and the coun-
tryside: at the beginning of a working day (city – 1702 CFU/m3, coun-
tryside – 2370 CFU/m3); in the middle of a working day (city – 2525
CFU/m3, countryside – 3366 CFU/m3); at the end of a working day (city
– 3701 CFU/m3, countryside – 3827 CFU/m3).
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Abstract
This article covers the necessity of periodontal disease prevention
at the individual level and development of new forms of peri-
odontal care.
Objective. To develop organizational and methodological principles for
performing individual medical and preventive activities for periodontal
disease as part of regular health examinations.
Materials and methods. A total of 150 patients in group 1 (common
preventive measures) and 150 patients in group 2 (individual approach)
aged 19–45 were examined. Various methods were used to specify the
extent and content of interventions, which included medical history, scan-
ning electron microscopy (SEM), and electron microprobe analysis
(EMPA).
Results. Periodontal disease prevention was performed in accordance
with the three-stage principle: selection, recording, monitoring.
Significant changes in oral hygiene status were registered in pa-
tients of group 2 in the 3 years after initiation of the program.
Among patients, 16.7% needed periodontal disease treatment,
which was 4.2-fold lower than before the preventive programs
were implemented. The reduction in clinical indices was greater
than 85%. These findings indicated increased resistance of tooth
enamel to caries. No significant changes were observed in the
oral hygiene status in patients of group 1 for the duration of
the observation period.
Conclusion. Based on the results, we can conclude that medical
and preventive activities based on dynamic observation contribute
to a significant decrease in the incidence and intensity of peri-
odontal pathology in certain groups of patients, as well as im-
proved teeth and oral mucosa health.
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Abstract
The functional pattern of the tongue neuromuscular apparatus and its
morphological characteristics plays an important role in the develop-
ment of the majority of malocclusion disorders. Based on an analysis
of the scientific literature, there is no unified position regarding the
research methodology and the treatment protocol for ankyloglossia
combined with malocclusion. In the present study, the strength pa-
rameters of tongue muscles were evaluated in patients with
ankyloglossia before and during the course of treatment. The research
program involved a group of patients with ankyloglossia which in-
cluded 39 children age 7 to 9 years. The control group included 20
children of similar age. In the patients of the base group,
motivational-oriented activities such as frenuloplasty, orthodontic
therapy, and instrumental myotherapy were conducted. The strength
parameters of the tongue were evaluated using the IOPI Medical
system. In the base group, a significant reduction in the strength of
the tongue elevation muscles was observed.
With closed mouth, the force parameters were reduced by 27.3%,
and with open mouth by 59.16%, in comparison with the results of
the control group (р<0.05). Functional therapy resulted in an in-
crease in the strength activity of the tongue as well as its endurance
indicators. Thus, the implementation of frenulotomy combined with
subsequent orthodontic therapy and myotherapy leads to an increase
in the strength parameters of the tongue muscles. The use of a
technology to increase children’s motivation for treatment is a de-
terminant of the enhancement of tongue muscle endurance and the
active remodeling of the tongue’s functional pattern.
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Abstract
A sequence of therapeutic and diagnostic stages of orthopedic
treatment and prophylaxis in patients with chronic oral mucosal
diseases based on the complex application of the soft base mate-
rial Mollosil plus and Hepon immunomodulating preparation has
been developed and described. Forty patients were divided into
groups. The patients underwent a complete dental examination, X-
ray studies, bacteriological examination, bacterioscopy and immu-
nological examination of saliva. The assessment of the condition
of the mucosa was carried out on days 3 and 10.
During the objective assessment of prosthetic bed mucosa, it was
revealed that the greatest number of patients with diffuse hyper-
emia had occurred on the third day. When studying the nature of
changes in the mucous membrane of the prosthetic bed, along the
integrity disturbance of the epithelial cover, on the third day after
the prosthetics, we registered a significantly lower amount of
traumatic erosion in 50% of patients who received an
immunomodulating therapy. In patients of this group, the content
of s-IgA in saliva increased significantly throughout the period of
observation, and the IgA and IgG values after a certain increase
on the tenth day subsequently returned to the baseline level
(0.125 ± 0.005 М ± m). The reduction in local humoral immunity
intensity in patients taking Hepon was accompanied by the acti-
vation of cellular immunity, which was evidenced by increased
phagocytic number (5.0 ± 0.3) and phagocytic index values
(42.0 ± 1.2). Throughout the period of adaptation to the prosthe-
ses, 80% of patients expressed positive dynamics in the reduction
of the area of inflammation by 20% (2.5-fold).
The effectiveness of treatment in patients with chronic oral mucosal dis-
eases was proved by the removable orthopedic prosthesis design on the
basis of clinical and laboratory studies of the complex application of
elastic base material and immunocorrection.
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Abstract
The search for available and effective products for inflammatory peri-
odontal disease prevention is an important objective in preventive
dentistry.
From a great variety of oral rinses, we chose the most commonly
used 0.05% chlorhexidine solution and the new preparation
Dentaseptin, due to the significance of their use for periodontal dis-
ease prevention.
We examined 50 patients aged 40–50 years; an unsatisfactory oral
hygiene index (more than 1.7) was observed in 70%, which indi-
cates the presence of inflammatory periodontal disease. The patients
were divided into two groups who brushed their teeth twice a day
with individually selected toothbrush and toothpaste. Twenty pa-
tients from the control group used chlorhexidine as an oral rinse,
and 30 patients from the study group used Dentaseptin for oral
cavity rinsing. The results in the study group showed 30% improve-
ment in oral health compared to the control patients (p<0.01), which
demonstrates its positive effects and opens the possibility for
recommending it for wide use in dentistry.
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Abstract
Nowadays there is a high demand for local anesthesia during a dental
patient visit. The follow-up rate of patients with cardiovascular disease is
one-third of the number applying for dental care (J. A. Baart, H. S. Brand,
2010, 2015). Prevention of the risk of complications in these patients with
the use of high-tech anesthetics is a priority for every dental doctor.
At the dental departments of Voronezh State Medical University, 100
patients aged 45–70 years were examined. Among these patients, 53%
applied for treatment of complicated forms of caries and 47% applied for
teeth removal due to complications of chronic periodontitis. The analysis
of medical histories of patients and their clinical records, as well as advi-
sory expert opinions, revealed the presence of cardiovascular disease. In
86% of cases, the examined had different cardiovascular diseases or their
combinations; 79% had hemodynamic disorders due to atherosclerosis of
the heart and brain vessels. As pain causes a significant increase in the
amount of adrenaline released during dental procedures, patients with
ischemic heart disease and essential hypertension need adequate
anesthesia.
Therefore, this category of patients was recommended for use of adrenaline
only at a dilution of 1:100.000 and 1:200.000 with restriction of its quantity.
Thus, the elimination of cardiovascular complications is explained by an
individualized approach to the choice of anesthetic during anesthesia, which
will allow for effective dental treatment. Keeping the oral cavity in good
condition plays a key role in general well-being and quality of life.
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In Russia, the principle criterion for children’s dental health is tradition-
ally considered the DMFT (total number of decayed, missing and filled
teeth) index. This criterion does not allow identification of individual risk
factors for dental health and, even more importantly, determining the
directions of individualized prevention of dental diseases.
The present research evaluates the informativeness of a number of the
European Community Health Indicators of dental health among 116
13-year-old schoolchildren from Voronezh, according to the following
criteria: the percentage of healthy children, the average value of the
DMFT index and its components, the prevalence of gingival bleeding,
and the oral hygiene index, as well as a number of subjective criteria
related to behavioral habits.
The objective indicators (dental status data) revealed the need for preven-
tive and/or non-emergency treatment in 93% and the need for emergency
dental treatment in 11%, among many others. The subjective indicators
(questionnaire survey data) revealed the ineffectiveness of preventive
measures in more than 53% of respondents.
European indicators of dental health have made it possible to assess the
main negative objective and subjective trends in society and to develop
mass and personalized preventive and hygienic measures [1, 2].
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Abstract
The primary detection and diagnosis of periodontal disease using con-
ventional diagnostic methods is not informative, does not reveal features
of the pathological process, and does not predict the outcome of therapy
based on etiology and pathogenesis. The gingival crevicular fluid is high-
ly informative in a study focused on searching for methods for the early
diagnosis and detection of periodontal disease. In our study, data of var-
ious parameters of the gingival crevicular fluid and its correlation with the
development of pathological processes in the periodontium are
summarised. Previously, we studied 120 subjects of both genders aged
18–25 years and analyzed data of cytological and bacterioscopic investi-
gations, public health research methods and physical examination, and
investigation of multiple enzymes in the gingival crevicular fluid. The
results revealed that at the early stages of inflammation in periodontal
tissue, the cocci population increases and forms clusters, mature
pseudomycelium of yeasts increases up to 8–10 colonies in the field of
view, and immature epithelial cells with nuclear-to-cytoplasmic ratio of
1:2 appear. Recent studies have shown that F. alocis has high potential for
the early diagnosis and detection of periodontal disease. This is due to the
fact thatF. alocis andP. gingivalis are able to generate mixed colonies and
coexist. For example, enzymes of F. alocis can induce P. gingivalis to
reproduce and spread, enhancing its virulence. Our preliminary data col-
lected in a study consisting of 45 subjects have shown interesting findings
in cytology and bacterioscopy. An increase in the number of F. alocis and
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P. gingivalis led to an increase in streptococci and fungi, and vice versa.
All of the above constitutes evidence that cytology and bacterioscopy are
highly informative methods for early detection of periodontal disease.
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The main reason for tooth loss is inflammatory periodontal dis-
ease. That is why early diagnostics, timely prevention and com-
plex treatment are necessary to relieve the inflammatory process
in order to recover or to achieve sustained remission within a
short time. Treatment should start with the removal of dental
calculus, plaque and biofilms from the teeth surfaces. The
Vector System (Durr-Dental, Germany) and ultrasonic scalers are
used for this. According to a number of authors, however, its
bactericidal effect is not enough to achieve sustained long-term
remission. Ozone therapy is considered an effective method of
treatment of inflammatory diseases. However, ozone has only a
superficial antimicrobial action.
Thus the purpose of our research was to assess the efficiency of complex
treatment of inflammatory periodontal disease using the Vector System
with ozonized water.
We examined 151 patients, who were divided into two groups:
the main group (91 people) and the control group (60 people).
The control patients received traditional treatment, and the main
group received vector therapy with ozonized water. Relief from
inflammation was achieved in a shorter time (on the second day)
in the main group, with treatment time reduced to half; 96% of
these patients experienced remission for 1 year, whereas 4% of
patients had only primary signs of inflammation. The patients inf
the control group experienced mild inflammation on the seventh
day, and remission lasted for 6 months in 43% and for 3 months
in 57% of patients.
The advantage of this method of periodontal disease treatment compared
to traditional treatment has been proven by clinical, bacterioscopic and
radiological indicators.
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Abstract
For 25 years we have been publishing research papers confirming the anti-
caries effect of fluoride in personswho have not reached a particular age (15.5
years) [1]. Unfortunately, at present, toothpastes with high fluo-
ride content are being promoted for both adults and children.
More than 150 patients between the ages of 20 and 40 were placed under our
observation, all of whom used the fluoride-free ROCS brand toothpaste to
maintain their oral hygiene. The control group comprised over 100 patients
who used toothpastes containing fluoride. The results were measured using
electron microscopy, and microchemical and clinical methods. The reduction
in caries was 84.5% in the study group and only 62.3% in the control group
(p<0.05). Electron and atomic force microscopy studies in the first group
showed that magnesium contained in the toothpaste was actively integrated
into the hydroxyapatite crystal cells in the enamel. The fluoride that was
present in the control group toothpaste was not detected on the chemical
spectrum of the enamel, but nevertheless had a strong bactericidal effect.
The studies showed that the presence of magnesium inside the enamel struc-
ture increased from 1.5 to 2.7 μmol/L (p<0.05) in adult patients, with only
trace amounts of fluoride found (0.1), confirming the fact that toothpastes
containingmagnesiumplay an active role in strengthening enamel crystal cells.
As such, electron and atomic force microscopy studies with
microchemical spectrum determination have confirmed the caries-
resistant effect (clinical) that occurs when using fluoride-free toothpaste.
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